Monoallelic	O
expression	O
of	O
Pax5	B-protein
:	O
a	O
paradigm	O
for	O
the	O
haploinsufficiency	O
of	O
mammalian	B-DNA
Pax	I-DNA
genes	I-DNA
?	O

It	O
is	O
generally	O
assumed	O
that	O
most	O
mammalian	B-DNA
genes	I-DNA
are	O
transcribed	O
from	O
both	O
alleles	B-DNA
.	O

Hence	O
,	O
the	O
diploid	O
state	O
of	O
the	O
genome	O
offers	O
the	O
advantage	O
that	O
a	O
loss-of-function	O
mutation	O
in	O
one	O
allele	B-DNA
can	O
be	O
compensated	O
for	O
by	O
the	O
remaining	O
wild-type	B-DNA
allele	I-DNA
of	O
the	O
same	O
gene	O
.	O

Indeed	O
,	O
the	O
vast	O
majority	O
of	O
human	O
disease	O
syndromes	O
and	O
engineered	O
mutations	O
in	O
the	O
mouse	B-DNA
genome	I-DNA
are	O
recessive	O
,	O
indicating	O
that	O
recessiveness	O
is	O
the	O
'default	O
'	O
state	O
.	O

However	O
,	O
a	O
minority	O
of	O
genes	O
are	O
semi-dominant	O
,	O
as	O
heterozygous	O
loss-of-function	O
mutation	O
in	O
these	O
genes	O
leads	O
to	O
phenotypic	O
abnormalities	O
.	O

This	O
condition	O
,	O
known	O
as	O
haploinsufficiency	O
,	O
has	O
been	O
described	O
for	O
five	O
of	O
the	O
nine	O
mammalian	B-DNA
Pax	I-DNA
genes	I-DNA
,	O
which	O
are	O
associated	O
with	O
mouse	O
developmental	O
mutants	O
and	O
human	O
disease	O
syndromes	O
.	O

Recently	O
we	O
have	O
reported	O
that	O
the	O
Pax5	B-DNA
gene	I-DNA
is	O
subject	O
to	O
allele	B-DNA
-specific	O
regulation	O
during	O
B	O
cell	O
development	O
.	O

Pax5	B-protein
is	O
predominantly	O
transcribed	O
from	O
only	O
one	O
of	O
its	O
two	O
alleles	B-DNA
in	O
early	B-cell_type
B-lymphoid	I-cell_type
progenitors	I-cell_type
and	O
mature	B-cell_type
B	I-cell_type
cells	I-cell_type
,	O
while	O
it	O
transiently	O
switches	O
to	O
a	O
biallelic	O
mode	O
of	O
transcription	O
in	O
pre-B	B-cell_type
and	I-cell_type
immature	I-cell_type
B	I-cell_type
cells	I-cell_type
.	O

As	O
a	O
consequence	O
,	O
B-lymphoid	O
tissues	O
are	O
mosaic	O
with	O
regard	O
to	O
the	O
transcribed	O
allele	B-DNA
,	O
and	O
heterozygous	O
mutation	O
of	O
Pax5	B-protein
therefore	O
results	O
in	O
deletion	O
of	O
B	B-cell_type
lymphocytes	I-cell_type
expressing	O
only	O
the	O
mutant	B-DNA
allele	I-DNA
.	O

The	O
allele	B-DNA
-specific	O
regulation	O
of	O
Pax5	B-protein
raises	O
the	O
intriguing	O
possibility	O
that	O
monoallelic	O
expression	O
may	O
also	O
be	O
the	O
mechanism	O
causing	O
the	O
haploinsufficiency	O
of	O
other	O
Pax	B-DNA
genes	I-DNA
.	O

In	O
this	O
review	O
,	O
we	O
discuss	O
different	O
models	O
accounting	O
for	O
the	O
haploinsufficiency	O
of	O
mammalian	B-DNA
Pax	I-DNA
genes	I-DNA
,	O
provide	O
further	O
evidence	O
in	O
support	O
of	O
the	O
allele	B-DNA
-specific	O
regulation	O
of	O
Pax5	B-protein
and	O
discuss	O
the	O
implication	O
of	O
these	O
findings	O
in	O
the	O
context	O
of	O
the	O
recent	O
literature	O
describing	O
the	O
stochastic	O
and	O
monoallelic	O
activation	O
of	O
other	O
hematopoietic	B-DNA
genes	I-DNA
.	O

Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
Vol	NULL
.	NULL

380	NULL
,	NULL
pp	NULL
.	NULL

601-611	NULL
,	NULL
June	NULL
1999	NULL
+	NULL
Copyright	NULL
Â©	NULL
by	NULL
Walter	NULL
de	NULL
Gruyter	NULL
:	NULL
Berlin	NULL
:	NULL
New	NULL
York	NULL
Review	NULL
Monoallelic	NULL
Expression	NULL
of	NULL
Pax5	NULL
:	NULL
A	NULL
Paradigm	NULL
for	NULL
the	NULL
Haploinsufficiency	NULL
of	NULL
Mammalian	NULL
Pax	NULL
Genes	NULL
?	NULL

Stephen	NULL
L.	NULL
Nutt	NULL
and	NULL
Meinrad	NULL
Busslinger'*	NULL
Research	NULL
Institute	NULL
of	NULL
Molecular	NULL
Pathology	NULL
,	NULL
Dr.	NULL
Bohr-Gasse	NULL
7	NULL
,	NULL
A-1030	NULL
Vienna	NULL
,	NULL
Austria	NULL
*	NULL
Corresponding	NULL
author	NULL
It	NULL
is	NULL
generally	NULL
assumed	NULL
that	NULL
most	NULL
mammalian	NULL
genes	NULL
are	NULL
transcribed	NULL
from	NULL
both	NULL
alleles	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
diploid	NULL
state	NULL
of	NULL
the	NULL
genome	NULL
offers	NULL
the	NULL
advantage	NULL
that	NULL
a	NULL
loss-of-function	NULL
mutation	NULL
in	NULL
one	NULL
allele	NULL
can	NULL
be	NULL
compensated	NULL
for	NULL
by	NULL
the	NULL
remaining	NULL
wild-type	NULL
allele	NULL
of	NULL
the	NULL
same	NULL
gene	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
human	NULL
disease	NULL
syndromes	NULL
and	NULL
engineered	NULL
mutations	NULL
in	NULL
the	NULL
mouse	NULL
genome	NULL
are	NULL
recessive	NULL
,	NULL
indicating	NULL
that	NULL
recessiveness	NULL
is	NULL
the	NULL
'de-fault	NULL
'	NULL
state	NULL
.	NULL

However	NULL
,	NULL
a	NULL
minority	NULL
of	NULL
genes	NULL
are	NULL
semi-dominant	NULL
,	NULL
as	NULL
heterozygous	NULL
loss-of-function	NULL
mutation	NULL
in	NULL
these	NULL
genes	NULL
leads	NULL
to	NULL
phenotypic	NULL
abnormalities	NULL
.	NULL

This	NULL
condition	NULL
,	NULL
known	NULL
as	NULL
haploinsufficiency	NULL
,	NULL
has	NULL
been	NULL
described	NULL
for	NULL
five	NULL
of	NULL
the	NULL
nine	NULL
mammalian	NULL
Pax	NULL
genes	NULL
,	NULL
which	NULL
are	NULL
associated	NULL
with	NULL
mouse	NULL
developmental	NULL
mutants	NULL
and	NULL
human	NULL
disease	NULL
syndromes	NULL
.	NULL

Recently	NULL
we	NULL
have	NULL
reported	NULL
that	NULL
the	NULL
Pax5	NULL
gene	NULL
is	NULL
subject	NULL
to	NULL
allele-specific	NULL
regulation	NULL
during	NULL
B	NULL
cell	NULL
development	NULL
.	NULL

is	NULL
predominantly	NULL
transcribed	NULL
from	NULL
only	NULL
one	NULL
of	NULL
its	NULL
two	NULL
alleles	NULL
in	NULL
early	NULL
B-lymphoid	NULL
progenitors	NULL
and	NULL
mature	NULL
B	NULL
cells	NULL
,	NULL
while	NULL
it	NULL
transiently	NULL
switches	NULL
to	NULL
a	NULL
biallelic	NULL
mode	NULL
of	NULL
transcription	NULL
in	NULL
pre-	NULL
B	NULL
and	NULL
immature	NULL
B	NULL
cells	NULL
.	NULL

As	NULL
a	NULL
con-sequence	NULL
,	NULL
B-lymphoid	NULL
tissues	NULL
are	NULL
mosaic	NULL
with	NULL
regard	NULL
to	NULL
the	NULL
transcribed	NULL
allele	NULL
,	NULL
and	NULL
heterozygous	NULL
mutation	NULL
of	NULL
Pax5	NULL
therefore	NULL
results	NULL
in	NULL
deletion	NULL
of	NULL
B	NULL
lymphocytes	NULL
expressing	NULL
only	NULL
the	NULL
mutant	NULL
allele	NULL
.	NULL

The	NULL
allele-specific	NULL
regulation	NULL
of	NULL
PaxS	NULL
raises	NULL
the	NULL
intriguing	NULL
possibility	NULL
that	NULL
monoallelic	NULL
expression	NULL
may	NULL
also	NULL
be	NULL
the	NULL
mechanism	NULL
causing	NULL
the	NULL
haploinsufficiency	NULL
of	NULL
other	NULL
Pax	NULL
genes	NULL
.	NULL

In	NULL
this	NULL
review	NULL
,	NULL
we	NULL
discuss	NULL
different	NULL
models	NULL
accounting	NULL
for	NULL
the	NULL
haploinsufficiency	NULL
of	NULL
mammalian	NULL
Pax	NULL
genes	NULL
,	NULL
provide	NULL
further	NULL
evidence	NULL
in	NULL
support	NULL
of	NULL
the	NULL
allele-specific	NULL
regulation	NULL
of	NULL
Pax5	NULL
and	NULL
discuss	NULL
the	NULL
implication	NULL
of	NULL
these	NULL
findings	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
recent	NULL
literature	NULL
describing	NULL
the	NULL
stochastic	NULL
and	NULL
monoallelic	NULL
activation	NULL
of	NULL
other	NULL
hematopoietic	NULL
genes	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
B	NULL
cell	NULL
development	NULL
/	NULL
Haploinsufficiency	NULL
/	NULL
Monoallelic	NULL
expression	NULL
/	NULL
Pax5	NULL
/	NULL
Single-cell	NULL
RT-PCR	NULL
.	NULL

Models	NULL
to	NULL
Account	NULL
for	NULL
Haploinsufficiency	NULL
The	NULL
genetic	NULL
term	NULL
haploinsufficiency	NULL
describes	NULL
a	NULL
situation	NULL
where	NULL
a	NULL
null	NULL
mutation	NULL
in	NULL
one	NULL
allele	NULL
of	NULL
a	NULL
gene	NULL
results	NULL
in	NULL
a	NULL
mutant	NULL
phenotype	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
second	NULL
,	NULL
wild-type	NULL
allele	NULL
.	NULL

A	NULL
haploinsufficient	NULL
gene	NULL
therefore	NULL
fulfills	NULL
its	NULL
normal	NULL
function	NULL
only	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
wild-type	NULL
alleles	NULL
,	NULL
and	NULL
hence	NULL
its	NULL
activity	NULL
is	NULL
highly	NULL
sensitive	NULL
to	NULL
gene	NULL
dosage	NULL
.	NULL

Haploinsufficiency	NULL
is	NULL
a	NULL
relatively	NULL
rare	NULL
genetic	NULL
phenomenon	NULL
in	NULL
mammals	NULL
,	NULL
as	NULL
the	NULL
majority	NULL
of	NULL
human	NULL
disease	NULL
syndromes	NULL
and	NULL
engineered	NULL
mouse	NULL
mutation	NULL
are	NULL
recessive	NULL
(	NULL
Fisher	NULL
and	NULL
Scambler	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
a	NULL
growing	NULL
number	NULL
of	NULL
mammalian	NULL
transcription	NULL
factor	NULL
genes	NULL
have	NULL
recently	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
haploinsufficient	NULL
(	NULL
Fisher	NULL
and	NULL
Scambler	NULL
,	NULL
1994	NULL
;	NULL
Engelkamp	NULL
and	NULL
van	NULL
Heyningen	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

While	NULL
several	NULL
explanations	NULL
for	NULL
haploinsufficiency	NULL
have	NULL
been	NULL
suggested	NULL
(	NULL
Wilkie	NULL
,	NULL
1994	NULL
;	NULL
Read	NULL
,	NULL
1995	NULL
)	NULL
,	NULL
we	NULL
will	NULL
discuss	NULL
below	NULL
only	NULL
the	NULL
three	NULL
most	NULL
likely	NULL
models	NULL
.	NULL

The	NULL
Protein-Protein	NULL
Interaction	NULL
Model	NULL
Transcription	NULL
factors	NULL
commonly	NULL
depend	NULL
on	NULL
the	NULL
interaction	NULL
with	NULL
partner	NULL
proteins	NULL
to	NULL
fulfill	NULL
their	NULL
functions	NULL
in	NULL
gene	NULL
activation	NULL
and	NULL
repression	NULL
.	NULL

Both	NULL
positive	NULL
and	NULL
negative	NULL
control	NULL
by	NULL
interacting	NULL
proteins	NULL
is	NULL
frequently	NULL
observed	NULL
for	NULL
transcription	NULL
factors	NULL
which	NULL
bind	NULL
DNA	NULL
as	NULL
heterodimeric	NULL
com-plexes	NULL
.	NULL

This	NULL
type	NULL
of	NULL
regulation	NULL
is	NULL
best	NULL
illustrated	NULL
by	NULL
the	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
which	NULL
interact	NULL
with	NULL
each	NULL
other	NULL
through	NULL
the	NULL
basic	NULL
helix-loop-helix	NULL
(	NULL
bHLH	NULL
)	NULL
domain	NULL
.	NULL

As	NULL
the	NULL
function	NULL
of	NULL
these	NULL
regulators	NULL
is	NULL
determined	NULL
by	NULL
the	NULL
relative	NULL
ratio	NULL
of	NULL
activating	NULL
and	NULL
inhibitory	NULL
HLH	NULL
proteins	NULL
(	NULL
Bain	NULL
and	NULL
Murre	NULL
,	NULL
1998	NULL
)	NULL
,	NULL
it	NULL
is	NULL
conceivable	NULL
that	NULL
a	NULL
two-fold	NULL
change	NULL
in	NULL
the	NULL
concentration	NULL
of	NULL
one	NULL
partner	NULL
protein	NULL
could	NULL
have	NULL
a	NULL
dramatic	NULL
effect	NULL
on	NULL
the	NULL
regulation	NULL
of	NULL
target	NULL
genes	NULL
within	NULL
the	NULL
cell	NULL
.	NULL

Indeed	NULL
,	NULL
several	NULL
bHLH	NULL
transcription	NULL
factors	NULL
including	NULL
Sisterless-b	NULL
(	NULL
Sis-b	NULL
)	NULL
play	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
Drosophila	NULL
sex	NULL
determination	NULL
where	NULL
they	NULL
cooperate	NULL
to	NULL
amplify	NULL
a	NULL
small	NULL
quantitative	NULL
(	NULL
two-fold	NULL
)	NULL
difference	NULL
in	NULL
sis	NULL
gene	NULL
dose	NULL
into	NULL
a	NULL
qualitative	NULL
all-or-none	NULL
effect	NULL
on	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
target	NULL
gene	NULL
Sex-lethal	NULL
(	NULL
Cline	NULL
,	NULL
1993	NULL
;	NULL
Parkhurst	NULL
and	NULL
Meneely	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

A	NULL
second	NULL
example	NULL
was	NULL
revealed	NULL
by	NULL
targeted	NULL
mutation	NULL
of	NULL
the	NULL
murine	NULL
E2A	NULL
gene	NULL
which	NULL
demonstrated	NULL
an	NULL
essential	NULL
role	NULL
for	NULL
this	NULL
bHLH	NULL
transcription	NULL
factor	NULL
in	NULL
B	NULL
cell	NULL
development	NULL
(	NULL
Bain	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Zhuang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
E2A	NULL
mutation	NULL
appears	NULL
to	NULL
be	NULL
haploinsuffi-cient	NULL
,	NULL
as	NULL
50	NULL
%	NULL
less	NULL
B	NULL
lymphocytes	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
fetal	NULL
liver	NULL
of	NULL
heterozygotes	NULL
compared	NULL
to	NULL
wild-type	NULL
embryos	NULL
(	NULL
Zhuang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
increased	NULL
expression	NULL
of	NULL
602	NULL
-	NULL
S.L	NULL
.	NULL

Nutt	NULL
etal	NULL
.	NULL

the	NULL
inhibitory	NULL
HLH	NULL
protein	NULL
Id1	NULL
in	NULL
the	NULL
B-lymphoid	NULL
lineage	NULL
resulted	NULL
in	NULL
a	NULL
phenotype	NULL
resembling	NULL
the	NULL
E24	NULL
null	NULL
mutation	NULL
(	NULL
Sun	NULL
,	NULL
1994	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
B-lymphopoiesis	NULL
is	NULL
extremely	NULL
sensitive	NULL
to	NULL
changes	NULL
in	NULL
the	NULL
relative	NULL
ratio	NULL
of	NULL
positively	NULL
and	NULL
negatively	NULL
acting	NULL
HLH	NULL
proteins	NULL
.	NULL

Binding	NULL
Site	NULL
Occupancy	NULL
Model	NULL
This	NULL
hypothesis	NULL
is	NULL
based	NULL
on	NULL
the	NULL
assumption	NULL
that	NULL
the	NULL
genome	NULL
contains	NULL
a	NULL
large	NULL
number	NULL
of	NULL
DNA-binding	NULL
sites	NULL
for	NULL
a	NULL
particular	NULL
transcription	NULL
factor	NULL
which	NULL
may	NULL
itself	NULL
be	NULL
present	NULL
only	NULL
in	NULL
limiting	NULL
amounts	NULL
within	NULL
the	NULL
cell	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
only	NULL
the	NULL
binding	NULL
sites	NULL
of	NULL
relatively	NULL
high	NULL
affinity	NULL
will	NULL
be	NULL
occupied	NULL
and	NULL
hence	NULL
potentially	NULL
regulated	NULL
by	NULL
the	NULL
transcription	NULL
factor	NULL
(	NULL
Read	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

A	NULL
small	NULL
increase	NULL
or	NULL
decrease	NULL
in	NULL
protein	NULL
concentration	NULL
could	NULL
consequently	NULL
lead	NULL
to	NULL
a	NULL
change	NULL
in	NULL
binding	NULL
site	NULL
occupancy	NULL
and	NULL
thus	NULL
to	NULL
an	NULL
altered	NULL
profile	NULL
of	NULL
target	NULL
gene	NULL
expression	NULL
.	NULL

Evidence	NULL
in	NULL
support	NULL
of	NULL
this	NULL
model	NULL
was	NULL
obtained	NULL
by	NULL
analysis	NULL
of	NULL
the	NULL
paired	NULL
domain-containing	NULL
transcription	NULL
factor	NULL
Pax6	NULL
(	NULL
Sched	NULL
!	NULL

et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Pax6	NULL
is	NULL
known	NULL
to	NULL
be	NULL
haploinsufficient	NULL
in	NULL
mammals	NULL
,	NULL
as	NULL
heterozygous	NULL
mutations	NULL
in	NULL
this	NULL
gene	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
Small	NULL
eye	NULL
phenotype	NULL
in	NULL
mouse	NULL
and	NULL
for	NULL
congenital	NULL
eye	NULL
abnormalitites	NULL
known	NULL
as	NULL
aniridia	NULL
and	NULL
Peters	NULL
'	NULL
anomaly	NULL
in	NULL
humans	NULL
(	NULL
Hanson	NULL
and	NULL
van	NULL
Heyningen	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
a	NULL
modest	NULL
increase	NULL
in	NULL
Pax6	NULL
expression	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
additional	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
Pax6	NULL
locus	NULL
generates	NULL
a	NULL
phenotype	NULL
which	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
heterozygous	NULL
Small	NULL
eye	NULL
mouse	NULL
(	NULL
Sched	NULL
!	NULL

et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
transcription	NULL
factor	NULL
Pax6	NULL
is	NULL
exquisitely	NULL
dosage-sensitive	NULL
,	NULL
as	NULL
it	NULL
can	NULL
control	NULL
normal	NULL
eye	NULL
development	NULL
only	NULL
within	NULL
a	NULL
narrow	NULL
concentration	NULL
range	NULL
.	NULL

The	NULL
Monoallelic	NULL
Expression	NULL
Model	NULL
A	NULL
third	NULL
possible	NULL
mechanism	NULL
to	NULL
account	NULL
for	NULL
haploinsufficiency	NULL
is	NULL
the	NULL
monoallelic	NULL
expression	NULL
theory	NULL
,	NULL
which	NULL
we	NULL
will	NULL
describe	NULL
in	NULL
detail	NULL
in	NULL
this	NULL
review	NULL
.	NULL

According	NULL
to	NULL
this	NULL
hypoth-esis	NULL
,	NULL
a	NULL
given	NULL
gene	NULL
is	NULL
transcribed	NULL
from	NULL
only	NULL
one	NULL
of	NULL
its	NULL
two	NULL
alleles	NULL
which	NULL
are	NULL
selected	NULL
for	NULL
expression	NULL
on	NULL
a	NULL
purely	NULL
stochastic	NULL
basis	NULL
.	NULL

Consequently	NULL
,	NULL
the	NULL
expressing	NULL
tissue	NULL
is	NULL
mo	NULL
wild	NULL
type	NULL
mutant	NULL
allele	NULL
1	NULL
allele	NULL
2	NULL
A	NULL
B	NULL
A	NULL
B	NULL
population	NULL
fuï¬irt	NULL
â	NULL
iin	NULL
I	NULL
l	NULL
l	NULL
null	NULL
Fig	NULL
.	NULL

1	NULL
_	NULL
Monoallelic	NULL
Expression	NULL
as	NULL
a	NULL
Possible	NULL
Cause	NULL
of	NULL
Haploin-sufficiency	NULL
.	NULL

Transcriptionally	NULL
active	NULL
and	NULL
silent	NULL
wild-type	NULL
alleles	NULL
of	NULL
a	NULL
given	NULL
cell	NULL
are	NULL
indicated	NULL
by	NULL
(	NULL
+	NULL
)	NULL
and	NULL
(	NULL
-	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

M	NULL
denotes	NULL
an	NULL
allele	NULL
carrying	NULL
a	NULL
null	NULL
mutation	NULL
.	NULL

The	NULL
expressing	NULL
tissue	NULL
of	NULL
a	NULL
heterozygous	NULL
individual	NULL
is	NULL
mosaic	NULL
with	NULL
regard	NULL
to	NULL
the	NULL
transcription	NULL
of	NULL
a	NULL
monoallelic	NULL
gene	NULL
,	NULL
as	NULL
it	NULL
consists	NULL
of	NULL
a	NULL
cell	NULL
population	NULL
A	NULL
expressing	NULL
the	NULL
wild-type	NULL
protein	NULL
(	NULL
V	NULL
)	NULL
and	NULL
a	NULL
population	NULL
B	NULL
lacking	NULL
any	NULL
functional	NULL
protein	NULL
{	NULL
null	NULL
)	NULL
.	NULL

saic	NULL
with	NULL
regard	NULL
to	NULL
transcription	NULL
of	NULL
this	NULL
gene	NULL
and	NULL
can	NULL
be	NULL
subdivided	NULL
into	NULL
two	NULL
cell	NULL
populations	NULL
,	NULL
each	NULL
transcribing	NULL
either	NULL
allele	NULL
1	NULL
or	NULL
2	NULL
,	NULL
respectively	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Both	NULL
cell	NULL
populations	NULL
can	NULL
participate	NULL
in	NULL
normal	NULL
development	NULL
and	NULL
differ-entiation	NULL
,	NULL
as	NULL
long	NULL
as	NULL
the	NULL
two	NULL
alleles	NULL
contain	NULL
wild-type	NULL
sequences	NULL
.	NULL

However	NULL
,	NULL
if	NULL
one	NULL
allele	NULL
is	NULL
mutated	NULL
,	NULL
one	NULL
cell	NULL
population	NULL
lacks	NULL
the	NULL
function	NULL
of	NULL
the	NULL
respective	NULL
gene	NULL
and	NULL
consequently	NULL
may	NULL
not	NULL
contribute	NULL
to	NULL
tissue	NULL
formation	NULL
,	NULL
thus	NULL
leading	NULL
to	NULL
developmental	NULL
abnormalities	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Haploinsufficiency	NULL
of	NULL
Mammalian	NULL
Pax	NULL
Genes	NULL
The	NULL
paired	NULL
box-containing	NULL
(	NULL
Pax	NULL
)	NULL
genes	NULL
constitute	NULL
a	NULL
highly	NULL
conserved	NULL
and	NULL
evolutionary	NULL
ancient	NULL
family	NULL
of	NULL
transcriptional	NULL
regulators	NULL
(	NULL
Noll	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

A	NULL
hallmark	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
is	NULL
the	NULL
so-called	NULL
paired	NULL
domain	NULL
(	NULL
Bopp	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
,	NULL
which	NULL
functions	NULL
as	NULL
a	NULL
bipartite	NULL
DNA-binding	NULL
motif	NULL
involved	NULL
in	NULL
target	NULL
gene	NULL
recognition	NULL
(	NULL
Czerny	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Xu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
mammalian	NULL
Pax	NULL
family	NULL
consists	NULL
of	NULL
nine	NULL
different	NULL
genes	NULL
(	NULL
Mansouri	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
and	NULL
is	NULL
of	NULL
special	NULL
interest	NULL
to	NULL
developmental	NULL
biologists	NULL
and	NULL
clinical	NULL
researchers	NULL
alike	NULL
,	NULL
as	NULL
natural	NULL
mutations	NULL
in	NULL
five	NULL
members	NULL
cause	NULL
developmental	NULL
disorders	NULL
in	NULL
mouse	NULL
and	NULL
human	NULL
(	NULL
Table	NULL
1	NULL
,	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
spectrum	NULL
of	NULL
the	NULL
observed	NULL
genetic	NULL
alterations	NULL
is	NULL
very	NULL
broad	NULL
,	NULL
ranging	NULL
from	NULL
single	NULL
base	NULL
changes	NULL
(	NULL
resulting	NULL
in	NULL
amino	NULL
acid	NULL
substitutions	NULL
and	NULL
splice	NULL
site	NULL
mutations	NULL
)	NULL
to	NULL
large	NULL
deletions	NULL
,	NULL
loss	NULL
of	NULL
function	NULL
is	NULL
the	NULL
common	NULL
denominator	NULL
of	NULL
all	NULL
these	NULL
mutations	NULL
.	NULL

Hence	NULL
,	NULL
these	NULL
developmental	NULL
disorders	NULL
arise	NULL
as	NULL
a	NULL
result	NULL
of	NULL
haploinsufficiency	NULL
(	NULL
Strachan	NULL
and	NULL
Read	NULL
,	NULL
1994	NULL
;	NULL
Hanson	NULL
and	NULL
van	NULL
Heyningen	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

Heterozygous	NULL
mutation	NULL
of	NULL
a	NULL
given	NULL
Pax	NULL
gene	NULL
is	NULL
known	NULL
to	NULL
result	NULL
in	NULL
considerable	NULL
phenotypic	NULL
variability	NULL
.	NULL

These	NULL
fluctuations	NULL
do	NULL
not	NULL
correlate	NULL
with	NULL
specific	NULL
mutations	NULL
and	NULL
are	NULL
seen	NULL
in	NULL
the	NULL
mouse	NULL
even	NULL
on	NULL
a	NULL
constant	NULL
genetic	NULL
background	NULL
(	NULL
Strachan	NULL
and	NULL
Read	NULL
,	NULL
1994	NULL
;	NULL
Table	NULL
1	NULL
-	NULL
Haploinsufficiency	NULL
and	NULL
Disease	NULL
Association	NULL
of	NULL
Human	NULL
and	NULL
Mouse	NULL
Pax	NULL
Genes	NULL
.	NULL

Gene	NULL
Human	NULL
disease	NULL
Mouse	NULL
mutant	NULL
Pax	NULL
!	NULL

n.d.	NULL
Undulated	NULL
Pax2	NULL
Renal-coloboma	NULL
Krd	NULL
syndrome	NULL
Pax3	NULL
Waardenburg	NULL
syndrome	NULL
_	NULL
Splotch	NULL
Pax6	NULL
Aniridia	NULL
Small	NULL
eye	NULL
Peters	NULL
'	NULL
anomaly	NULL
Pax8	NULL
Hypothyroidism	NULL
n.d	NULL
.	NULL

The	NULL
indicated	NULL
human	NULL
disease	NULL
syndromes	NULL
and	NULL
mouse	NULL
developmental	NULL
mutants	NULL
are	NULL
caused	NULL
by	NULL
heterozygous	NULL
mutations	NULL
in	NULL
five	NULL
different	NULL
Paxgenes	NULL
(	NULL
reviewed	NULL
by	NULL
Strachan	NULL
and	NULL
Read	NULL
,	NULL
1994	NULL
;	NULL
Hanson	NULL
and	NULL
van	NULL
Heyningen	NULL
,	NULL
1995	NULL
;	NULL
Mansouri	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

References	NULL
of	NULL
the	NULL
original	NULL
publications	NULL
:	NULL
renal-coloboma	NULL
syndrome	NULL
(	NULL
Sanyanusin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
Waardenburg	NULL
syndrome	NULL
(	NULL
Baldwin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Tass-abehji	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
aniridia	NULL
(	NULL
Ton	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
Peters	NULL
'	NULL
anomaly	NULL
(	NULL
Hanson	NULL
ef	NULL
a/	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
congenital	NULL
hypothyroidism	NULL
(	NULL
Macchia	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
,	NULL
Undulated	NULL
(	NULL
Wilm	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
,	NULL
Krd	NULL
(	NULL
kidney	NULL
and	NULL
retinal	NULL
de-fects	NULL
)	NULL
(	NULL
Keller	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
Splotch	NULL
(	NULL
Epstein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
Small	NULL
eye	NULL
(	NULL
Hill	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

n.d.	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

Hanson	NULL
and	NULL
van	NULL
Heyningen	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
haploinsufficient	NULL
phenotype	NULL
of	NULL
a	NULL
Paxgene	NULL
is	NULL
restricted	NULL
to	NULL
only	NULL
a	NULL
subset	NULL
of	NULL
its	NULL
expression	NULL
domains	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
heterozygous	NULL
Pax6	NULL
mutations	NULL
cause	NULL
malformations	NULL
only	NULL
in	NULL
the	NULL
eye	NULL
,	NULL
although	NULL
this	NULL
gene	NULL
is	NULL
widely	NULL
expressed	NULL
in	NULL
the	NULL
developing	NULL
central	NULL
nervous	NULL
system	NULL
,	NULL
nose	NULL
and	NULL
pancreas	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
developing	NULL
eye	NULL
(	NULL
Walther	NULL
and	NULL
Gruss	NULL
,	NULL
1991	NULL
;	NULL
Callaerts	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
haploinsufficient	NULL
phenotypes	NULL
are	NULL
relatively	NULL
mild	NULL
compared	NULL
to	NULL
the	NULL
homozygous	NULL
null	NULL
mutations	NULL
which	NULL
are	NULL
lethal	NULL
for	NULL
most	NULL
Paxgenes	NULL
analyzed	NULL
in	NULL
the	NULL
mouse	NULL
(	NULL
Mansouri	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
function	NULL
of	NULL
Pax	NULL
transcription	NULL
factors	NULL
appears	NULL
to	NULL
be	NULL
highly	NULL
dosage-sensitive	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
moderate	NULL
overexpression	NULL
of	NULL
Pax6	NULL
generates	NULL
a	NULL
similar	NULL
phenotype	NULL
as	NULL
inactivation	NULL
of	NULL
one	NULL
of	NULL
the	NULL
two	NULL
Pax6	NULL
alleles	NULL
(	NULL
Sched|	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

To	NULL
date	NULL
,	NULL
the	NULL
molecular	NULL
mechanism	NULL
responsible	NULL
for	NULL
this	NULL
dosage	NULL
sensitivity	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
elucidated	NULL
.	NULL

This	NULL
phenomenon	NULL
may	NULL
be	NULL
partly	NULL
explained	NULL
by	NULL
the	NULL
binding	NULL
site	NULL
occupancy	NULL
model	NULL
(	NULL
see	NULL
above	NULL
;	NULL
Sched	NULL
!	NULL

et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

However	NULL
,	NULL
no	NULL
evidence	NULL
for	NULL
strongly	NULL
interacting	NULL
Pax	NULL
partner	NULL
proteins	NULL
exists	NULL
to	NULL
date	NULL
nor	NULL
is	NULL
dimerization	NULL
required	NULL
for	NULL
DNA-binding	NULL
of	NULL
Pax	NULL
proteins	NULL
(	NULL
Czerny	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
it	NULL
seems	NULL
unlikely	NULL
that	NULL
the	NULL
function	NULL
of	NULL
Pax	NULL
transcription	NULL
factors	NULL
is	NULL
titrat-ed	NULL
within	NULL
the	NULL
cell	NULL
by	NULL
strong	NULL
protein-protein	NULL
interactions	NULL
.	NULL

Our	NULL
recent	NULL
data	NULL
on	NULL
the	NULL
allele-specific	NULL
regulation	NULL
of	NULL
Pax5	NULL
(	NULL
Nutt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
raise	NULL
,	NULL
however	NULL
,	NULL
the	NULL
possibility	NULL
that	NULL
monoallelic	NULL
expression	NULL
may	NULL
be	NULL
an	NULL
important	NULL
mechanism	NULL
causing	NULL
the	NULL
haploinsufficiency	NULL
of	NULL
Paxgenes	NULL
.	NULL

The	NULL
Heterozygous	NULL
Pax5	NULL
Mutant	NULL
Mouse	NULL
as	NULL
a	NULL
Model	NULL
System	NULL
to	NULL
Test	NULL
the	NULL
Monoallelic	NULL
Expression	NULL
Theory	NULL
The	NULL
Pax5gene	NULL
coding	NULL
for	NULL
the	NULL
B	NULL
cell-specific	NULL
activator	NULL
protein	NULL
(	NULL
BSAP	NULL
)	NULL
is	NULL
expressed	NULL
throughout	NULL
B	NULL
cell	NULL
development	NULL
except	NULL
in	NULL
terminally	NULL
differentiated	NULL
plasma	NULL
cells	NULL
(	NULL
Adams	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
.	NULL

Targeted	NULL
inactivation	NULL
of	NULL
PaxS	NULL
arrests	NULL
B-lymphopoiesis	NULL
at	NULL
an	NULL
early	NULL
pro-	NULL
B	NULL
cell	NULL
stage	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
of	NULL
adult	NULL
mice	NULL
,	NULL
while	NULL
PaxS	NULL
is	NULL
already	NULL
required	NULL
for	NULL
the	NULL
generation	NULL
of	NULL
the	NULL
earliest	NULL
B-lineage	NULL
committed	NULL
precursor	NULL
cells	NULL
in	NULL
the	NULL
fetal	NULL
liver	NULL
(	NULL
Urbanek	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Nutt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
(	NULL
see	NULL
Figure	NULL
2A	NULL
)	NULL
.	NULL

Pax5-deficient	NULL
mice	NULL
also	NULL
display	NULL
abnormal	NULL
patterning	NULL
of	NULL
the	NULL
midbrain	NULL
and	NULL
anterior	NULL
cerebellum	NULL
(	NULL
Urbanek	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
consistent	NULL
with	NULL
expression	NULL
of	NULL
Pax5	NULL
at	NULL
the	NULL
midbrain-hindbrain	NULL
boundary	NULL
during	NULL
CNS	NULL
development	NULL
(	NULL
Adams	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
Pax5	NULL
target	NULL
genes	NULL
has	NULL
been	NULL
greatly	NULL
facilitated	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
Pax5-deficient	NULL
pro-	NULL
B	NULL
cells	NULL
can	NULL
be	NULL
readily	NULL
established	NULL
as	NULL
long-term	NULL
in	NULL
vifro	NULL
cultures	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
stromal	NULL
cells	NULL
and	NULL
interleukin-7	NULL
(	NULL
Nutt	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

CD19	NULL
,	NULL
coding	NULL
for	NULL
a	NULL
B	NULL
cell	NULL
surface	NULL
protein	NULL
,	NULL
is	NULL
a	NULL
particularly	NULL
interesting	NULL
target	NULL
gene	NULL
,	NULL
as	NULL
its	NULL
expression	NULL
is	NULL
entirely	NULL
lost	NULL
in	NULL
Pax5-deficient	NULL
pro-B	NULL
cells	NULL
(	NULL
Nutt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

CD19	NULL
expression	NULL
can	NULL
,	NULL
however	NULL
,	NULL
be	NULL
fully	NULL
reactivated	NULL
in	NULL
these	NULL
cells	NULL
by	NULL
an	NULL
estrogen-	NULL
inducible	NULL
version	NULL
(	NULL
BSAP-ER	NULL
)	NULL
of	NULL
Pax5	NULL
(	NULL
Nutt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
Pax5	NULL
is	NULL
known	NULL
to	NULL
regulate	NULL
the	NULL
CD19	NULL
gene	NULL
by	NULL
binding	NULL
to	NULL
a	NULL
high-affinity	NULL
site	NULL
in	NULL
the	NULL
Monoallelic	NULL
Transcription	NULL
of	NULL
Pax	NULL
Genes	NULL
603	NULL
-30	NULL
promoter	NULL
region	NULL
(	NULL
Kozmik	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
CD19	NULL
was	NULL
demonstrated	NULL
by	NULL
loss-	NULL
and	NULL
gain-of-function	NULL
experiments	NULL
to	NULL
be	NULL
a	NULL
bona	NULL
fide	NULL
target	NULL
gene	NULL
whose	NULL
expression	NULL
is	NULL
strictly	NULL
dependent	NULL
on	NULL
Pax5	NULL
function	NULL
.	NULL

A	NULL
direct	NULL
test	NULL
of	NULL
the	NULL
monoallelic	NULL
expression	NULL
hypothesis	NULL
depends	NULL
on	NULL
the	NULL
possibility	NULL
to	NULL
follow	NULL
the	NULL
transcription	NULL
of	NULL
individual	NULL
Paxgene	NULL
alleles	NULL
in	NULL
vivo	NULL
.	NULL

Importantly	NULL
,	NULL
such	NULL
a	NULL
possibility	NULL
was	NULL
provided	NULL
by	NULL
the	NULL
analysis	NULL
of	NULL
B	NULL
lymphocytes	NULL
from	NULL
heterozygous	NULL
Pax5	NULL
(	NULL
+/-	NULL
)	NULL
mice	NULL
for	NULL
the	NULL
following	NULL
reasons	NULL
.	NULL

First	NULL
,	NULL
as	NULL
stated	NULL
above	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
CD19	NULL
is	NULL
totally	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
Pax5	NULL
,	NULL
indicating	NULL
that	NULL
CD19	NULL
is	NULL
an	NULL
ideal	NULL
marker	NULL
for	NULL
Pax5	NULL
function	NULL
(	NULL
Nutt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
1998	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
only	NULL
cells	NULL
transcribing	NULL
the	NULL
wild-type	NULL
Pax5	NULL
allele	NULL
express	NULL
CD19	NULL
on	NULL
the	NULL
surface	NULL
and	NULL
can	NULL
thus	NULL
be	NULL
detected	NULL
as	NULL
CD19*	NULL
cells	NULL
by	NULL
anti-CD19	NULL
antibody	NULL
staining	NULL
and	NULL
flow	NULL
cytometric	NULL
analysis	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
inactivated	NULL
PaxS	NULL
allele	NULL
contains	NULL
an	NULL
in-frame	NULL
lacgene	NULL
insertion	NULL
,	NULL
and	NULL
hence	NULL
its	NULL
transcription	NULL
leads	NULL
to	NULL
the	NULL
synthesis	NULL
of	NULL
B-galactosidase	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
which	NULL
can	NULL
also	NULL
be	NULL
monitored	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
using	NULL
a	NULL
fluorogenic	NULL
substrate	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
compartments	NULL
of	NULL
heterozygous	NULL
Pax5	NULL
(	NULL
+/-	NULL
)	NULL
fetal	NULL
liver	NULL
and	NULL
bone	NULL
marrow	NULL
demonstrated	NULL
that	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
pro-	NULL
B	NULL
cells	NULL
express	NULL
only	NULL
the	NULL
CD19	NULL
protein	NULL
,	NULL
but	NULL
no	NULL
B-galactosidase	NULL
activity	NULL
(	NULL
Nutt	NULL
et	NULL
a.	NULL
,	NULL
1999	NULL
)	NULL
(	NULL
Figure	NULL
2D	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
most	NULL
heterozygous	NULL
pro-	NULL
B	NULL
cells	NULL
express	NULL
exclusively	NULL
the	NULL
wild-type	NULL
Paxd	NULL
allele	NULL
in	NULL
vivo	NULL
,	NULL
indicating	NULL
that	NULL
PaxS5	NULL
is	NULL
monoallelically	NULL
transcribed	NULL
at	NULL
the	NULL
onset	NULL
of	NULL
B	NULL
lymphopoiesis	NULL
.	NULL

Monoallelic	NULL
expression	NULL
also	NULL
predominates	NULL
in	NULL
mature	NULL
B	NULL
cells	NULL
of	NULL
the	NULL
spleen	NULL
and	NULL
lymph	NULL
node	NULL
,	NULL
while	NULL
PaxSis	NULL
transcribed	NULL
from	NULL
both	NULL
alleles	NULL
in	NULL
pre-	NULL
B	NULL
and	NULL
immature	NULL
B	NULL
cells	NULL
(	NULL
Nutt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
(	NULL
Figure	NULL
2C	NULL
,	NULL
D	NULL
)	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
allelic	NULL
PaxS5	NULL
transcription	NULL
is	NULL
therefore	NULL
regulated	NULL
during	NULL
B	NULL
cell	NULL
development	NULL
.	NULL

This	NULL
regulation	NULL
is	NULL
furthermore	NULL
independent	NULL
of	NULL
the	NULL
parental	NULL
origin	NULL
of	NULL
the	NULL
two	NULL
Pax5	NULL
alleles	NULL
(	NULL
Nutt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
monoallelic	NULL
expression	NULL
of	NULL
Pax5	NULL
is	NULL
not	NULL
caused	NULL
by	NULL
genomic	NULL
imprinting	NULL
which	NULL
normally	NULL
restricts	NULL
expression	NULL
either	NULL
to	NULL
the	NULL
maternal	NULL
or	NULL
paternal	NULL
allele	NULL
(	NULL
Barlow	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
phenomenon	NULL
of	NULL
monoallelic	NULL
Pax5	NULL
expression	NULL
was	NULL
further	NULL
investigated	NULL
by	NULL
establishing	NULL
pro-B	NULL
cell	NULL
lines	NULL
from	NULL
heterozygous	NULL
mice	NULL
in	NULL
vitro	NULL
.	NULL

Single-cell	NULL
cloning	NULL
experiments	NULL
and	NULL
time	NULL
course	NULL
analyses	NULL
demonstrated	NULL
that	NULL
individual	NULL
cell	NULL
colonies	NULL
were	NULL
able	NULL
to	NULL
switch	NULL
expression	NULL
between	NULL
alleles	NULL
within	NULL
two	NULL
weeks	NULL
(	NULL
Nutt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
replication	NULL
timing	NULL
analyses	NULL
by	NULL
fluorescence	NULL
in	NULL
sifu	NULL
hybridization	NULL
(	NULL
FISH	NULL
)	NULL
demonstrated	NULL
that	NULL
both	NULL
Pax5	NULL
alleles	NULL
are	NULL
synchronously	NULL
replicated	NULL
during	NULL
the	NULL
S-phase	NULL
in	NULL
B	NULL
cells	NULL
of	NULL
heterozygous	NULL
mice	NULL
(	NULL
Nutt	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
the	NULL
allele-specific	NULL
regulation	NULL
of	NULL
PaxS	NULL
is	NULL
stochastic	NULL
,	NULL
reversible	NULL
,	NULL
independent	NULL
of	NULL
parental	NULL
origin	NULL
and	NULL
does	NULL
not	NULL
correlate	NULL
with	NULL
asynchronous	NULL
replication	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
monoallelic	NULL
expression	NULL
of	NULL
genomically	NULL
imprinted	NULL
genes	NULL
(	NULL
Barlow	NULL
,	NULL
1995	NULL
;	NULL
Watanabe	NULL
and	NULL
Barlow	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

As	NULL
predicted	NULL
by	NULL
the	NULL
model	NULL
shown	NULL
in	NULL
Figure	NULL
1	NULL
,	NULL
the	NULL
monoallelic	NULL
expression	NULL
of	NULL
Pax5gen-erates	NULL
a	NULL
haploinsufficient	NULL
phenotype	NULL
at	NULL
the	NULL
cellular	NULL
level	NULL
in	NULL
heterozygous	NULL
Pax5	NULL
(	NULL
+/-	NULL
)	NULL
mice	NULL
.	NULL

Cells	NULL
which	NULL
express	NULL
only	NULL
the	NULL
mutant	NULL
(	NULL
facZ	NULL
)	NULL
allele	NULL
are	NULL
absent	NULL
in	NULL
the	NULL
B-lymphoid	NULL
lineage	NULL
past	NULL
the	NULL
developmental	NULL
block	NULL
of	NULL
the	NULL
Pax5	NULL
mutation	NULL
604	NULL
-	NULL
S.L	NULL
.	NULL

Nutt	NULL
etal	NULL
.	NULL

A	NULL
fetal	NULL
bone	NULL
liver	NULL
marrow	NULL
lymphoid	NULL
early	NULL
late	NULL
B	NULL
-	NULL
>	NULL
-	NULL
>	NULL
progenitor	NULL
pro-B	NULL
pro-B	NULL
-	NULL
>	NULL
pre-	NULL
-	NULL
>	NULL
B	NULL
cell	NULL
B	NULL
cell	NULL
cell	NULL
Pax5	NULL
B	NULL
wt	NULL
Pax5	NULL
*	NULL
(	NULL
mAb	NULL
detection	NULL
)	NULL
poly	NULL
A	NULL
targeted	NULL
\	NULL
\	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
itl	NULL
|	NULL
lacZ	NULL
-	NULL
--	NULL
-	NULL
Â»	NULL
C	NULL
lymph	NULL
node	NULL
:	NULL
gated	NULL
on	NULL
B220*cells	NULL
10+	NULL
CD19	NULL
10Â°	NULL
10Â°	NULL
10+	NULL
LAGZ	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
Â»	NULL
immature	NULL
mature	NULL
plasma	NULL
CD19	NULL
expression	NULL
|	NULL
4	NULL
I	NULL
?	NULL

r	NULL
fallal	NULL
mono-biallelic	NULL
allelic	NULL
B-galactosidase	NULL
|	NULL
;	NULL
.	NULL

m	NULL
+	NULL
{	NULL
staining	NULL
)	NULL
100	NULL
G	NULL
L	NULL
r	NULL
2	NULL
ol	NULL
O	NULL
y	NULL
5	NULL
e	NULL
Â§	NULL
E	NULL
25	NULL
6	NULL
S	NULL
a	NULL
]	NULL
m	NULL
m	NULL
a	NULL
C	NULL
o	NULL
Â®	NULL
o	NULL
g	NULL
8	NULL
=	NULL
``	NULL
a	NULL
.	NULL

3	NULL
3	NULL
TC	NULL
o	NULL
a	NULL
â¬	NULL
E	NULL
E	NULL
L________J	NULL
L__J	NULL
bone	NULL
spleen	NULL
lymph	NULL
marrow	NULL
node	NULL
Fig	NULL
.	NULL

2	NULL
-	NULL
Allele-Specific	NULL
Regulation	NULL
of	NULL
PaxS	NULL
in	NULL
B	NULL
Lymphocytes	NULL
of	NULL
Heterozygous	NULL
Pax5	NULL
(	NULL
+/-	NULL
)	NULL
Mice	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
different	NULL
stages	NULL
of	NULL
B	NULL
cell	NULL
development	NULL
are	NULL
schematically	NULL
shown	NULL
together	NULL
with	NULL
the	NULL
PaxS	NULL
expression	NULL
pattern	NULL
and	NULL
the	NULL
early	NULL
developmental	NULL
block	NULL
observed	NULL
in	NULL
fetal	NULL
and	NULL
adult	NULL
B	NULL
lymphopoiesis	NULL
of	NULL
PaxS	NULL
(	NULL
-	NULL
)	NULL
mice	NULL
(	NULL
Nutt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Schematic	NULL
diagram	NULL
of	NULL
the	NULL
wild-type	NULL
and	NULL
disrupted	NULL
alleles	NULL
,	NULL
explaining	NULL
the	NULL
experimental	NULL
system	NULL
used	NULL
for	NULL
demonstrating	NULL
allele-specific	NULL
regulation	NULL
of	NULL
PaxS	NULL
in	NULL
heterozygous	NULL
mutant	NULL
(	NULL
+/-	NULL
)	NULL
mice	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Mono-	NULL
and	NULL
biallelically	NULL
expressing	NULL
B	NULL
lymphocytes	NULL
in	NULL
the	NULL
lymph	NULL
node	NULL
of	NULL
PaxSÂ§	NULL
(	NULL
+/-	NULL
)	NULL
mice	NULL
.	NULL

Single-cell	NULL
suspensions	NULL
prepared	NULL
from	NULL
lymph	NULL
nodes	NULL
were	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
anti-B220	NULL
and	NULL
anti-CD19	NULL
antibodies	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
fluorogenic	NULL
B-galactosidase	NULL
substrate	NULL
CMFDG	NULL
as	NULL
described	NULL
(	NULL
Nutt	NULL
ef	NULL
a/	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

B220*	NULL
B-lymphocytes	NULL
were	NULL
gated	NULL
,	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
CD19	NULL
and	NULL
LacZ	NULL
within	NULL
this	NULL
population	NULL
is	NULL
displayed	NULL
.	NULL

(	NULL
D	NULL
)	NULL
The	NULL
proportion	NULL
of	NULL
monoallelically	NULL
expressing	NULL
cells	NULL
,	NULL
as	NULL
determined	NULL
in	NULL
the	NULL
PaxS	NULL
(	NULL
+/-	NULL
)	NULL
mouse	NULL
model	NULL
(	NULL
Nutt	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
,	NULL
is	NULL
indicated	NULL
for	NULL
different	NULL
stages	NULL
of	NULL
B	NULL
cell	NULL
development	NULL
.	NULL

(	NULL
Nutt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
(	NULL
Figure	NULL
2C	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
Pax5	NULL
(	NULL
+/-	NULL
)	NULL
mouse	NULL
has	NULL
been	NULL
ideal	NULL
to	NULL
prove	NULL
the	NULL
monoallelic	NULL
expression	NULL
theory	NULL
,	NULL
although	NULL
it	NULL
is	NULL
phenotypically	NULL
normal	NULL
and	NULL
does	NULL
not	NULL
provide	NULL
a	NULL
model	NULL
for	NULL
a	NULL
human	NULL
inherited	NULL
disease	NULL
.	NULL

The	NULL
main	NULL
reasons	NULL
for	NULL
this	NULL
apparent	NULL
discrepancy	NULL
are	NULL
the	NULL
functional	NULL
redundancy	NULL
of	NULL
Pax2	NULL
and	NULL
Pax5	NULL
in	NULL
the	NULL
developing	NULL
midbrain	NULL
(	NULL
Urbanek	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Schwarz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
and	NULL
the	NULL
fact	NULL
that	NULL
a	NULL
two-fold	NULL
reduction	NULL
in	NULL
B	NULL
cells	NULL
is	NULL
without	NULL
phenotypic	NULL
consequence	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
human	NULL
PAXS	NULL
gene	NULL
could	NULL
not	NULL
be	NULL
linked	NULL
to	NULL
a	NULL
primary	NULL
immunodeficiency	NULL
syndrome	NULL
(	NULL
Vorechovsky	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Testing	NULL
the	NULL
Monoallelic	NULL
Expression	NULL
Hypothesis	NULL
in	NULL
Genetically	NULL
Unmanipulated	NULL
B	NULL
Cells	NULL
...	NULL

The	NULL
evidence	NULL
presented	NULL
above	NULL
is	NULL
persuasive	NULL
that	NULL
the	NULL
two	NULL
Pax5	NULL
alleles	NULL
are	NULL
independently	NULL
regulated	NULL
in	NULL
B-lymphoid	NULL
cells	NULL
of	NULL
heterozygous	NULL
mutant	NULL
mice	NULL
.	NULL

While	NULL
the	NULL
B	NULL
lymphocytes	NULL
of	NULL
these	NULL
mice	NULL
all	NULL
transcribe	NULL
the	NULL
wild-type	NULL
PaxSallele	NULL
,	NULL
a	NULL
variable	NULL
number	NULL
of	NULL
B	NULL
cells	NULL
,	NULL
depending	NULL
on	NULL
their	NULL
developmental	NULL
stage	NULL
,	NULL
also	NULL
expresses	NULL
the	NULL
targeted	NULL
allele	NULL
(	NULL
Figure	NULL
2D	NULL
)	NULL
.	NULL

These	NULL
results	NULL
can	NULL
be	NULL
interpreted	NULL
in	NULL
two	NULL
ways	NULL
.	NULL

First	NULL
,	NULL
Pax5is	NULL
regulated	NULL
in	NULL
an	NULL
allele-specific	NULL
manner	NULL
during	NULL
B	NULL
cell	NULL
development	NULL
which	NULL
is	NULL
characterized	NULL
by	NULL
distinct	NULL
phases	NULL
of	NULL
predominantly	NULL
mono-	NULL
or	NULL
biallelic	NULL
Pax5	NULL
transcription	NULL
(	NULL
Nutt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
targeted	NULL
(	NULL
lacZ	NULL
)	NULL
allele	NULL
has	NULL
been	NULL
adversely	NULL
affected	NULL
by	NULL
insertion	NULL
of	NULL
the	NULL
lacZ/neomycin	NULL
expression	NULL
cassette	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
the	NULL
mosaic	NULL
expression	NULL
pattern	NULL
of	NULL
Pax5	NULL
may	NULL
simply	NULL
reflect	NULL
dysregulation	NULL
of	NULL
the	NULL
targeted	NULL
allele	NULL
.	NULL

Evidence	NULL
against	NULL
the	NULL
latter	NULL
argument	NULL
is	NULL
provided	NULL
by	NULL
the	NULL
expression	NULL
analysis	NULL
of	NULL
in	NULL
vitro	NULL
cultured	NULL
Pax5	NULL
(	NULL
+/-	NULL
)	NULL
pro-B	NULL
cells	NULL
(	NULL
Nutt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

We	NULL
could	NULL
clearly	NULL
demonstrate	NULL
that	NULL
pro-B	NULL
cells	NULL
transcribing	NULL
the	NULL
wild-type	NULL
Pax5	NULL
allele	NULL
in	NULL
vivo	NULL
could	NULL
switch	NULL
expression	NULL
from	NULL
the	NULL
wild-type	NULL
to	NULL
the	NULL
targeted	NULL
allele	NULL
upon	NULL
in	NULL
vifro	NULL
culture	NULL
,	NULL
thus	NULL
indicating	NULL
that	NULL
the	NULL
targeted	NULL
lacZ	NULL
allele	NULL
can	NULL
be	NULL
fully	NULL
active	NULL
in	NULL
pro-	NULL
B	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
wild-type	NULL
Pax5	NULL
allele	NULL
lacking	NULL
any	NULL
genetic	NULL
modification	NULL
is	NULL
transcriptionally	NULL
silenced	NULL
under	NULL
these	NULL
conditions	NULL
,	NULL
while	NULL
this	NULL
phenomenon	NULL
was	NULL
never	NULL
observed	NULL
with	NULL
cultured	NULL
pro-B	NULL
cells	NULL
from	NULL
wild-type	NULL
mice	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
insertion	NULL
of	NULL
a	NULL
neomycin	NULL
selection	NULL
cassette	NULL
upon	NULL
gene	NULL
targeting	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
affect	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
several	NULL
other	NULL
genes	NULL
in	NULL
the	NULL
mouse	NULL
.	NULL

An	NULL
illustrative	NULL
example	NULL
is	NULL
the	NULL
disruption	NULL
of	NULL
the	NULL
myf6	NULL
gene	NULL
,	NULL
which	NULL
codes	NULL
for	NULL
a	NULL
bHLH	NULL
transcription	NULL
factor	NULL
involved	NULL
in	NULL
myogenesis	NULL
.	NULL

Three	NULL
different	NULL
myfÃ©null	NULL
alleles	NULL
have	NULL
been	NULL
reported	NULL
which	NULL
result	NULL
in	NULL
distinct	NULL
phenotypes	NULL
ranging	NULL
from	NULL
complete	NULL
viability	NULL
to	NULL
lethality	NULL
of	NULL
the	NULL
homozygotes	NULL
(	NULL
Olson	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

These	NULL
phenotypic	NULL
differences	NULL
are	NULL
caused	NULL
by	NULL
the	NULL
specific	NULL
orientation	NULL
and	NULL
position	NULL
of	NULL
the	NULL
inserted	NULL
neomycin	NULL
gene	NULL
which	NULL
can	NULL
interfere	NULL
with	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
neighbouring	NULL
myogenic	NULL
gene	NULL
myf5	NULL
(	NULL
Olson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Due	NULL
to	NULL
the	NULL
large	NULL
size	NULL
of	NULL
the	NULL
PaxS	NULL
locus	NULL
(	NULL
Busslinger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
the	NULL
insertion	NULL
of	NULL
the	NULL
neomycin	NULL
gene	NULL
affects	NULL
the	NULL
regulation	NULL
of	NULL
an	NULL
adjacent	NULL
gene	NULL
which	NULL
furthermore	NULL
would	NULL
have	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
Pax5	NULL
.	NULL

The	NULL
neomycin	NULL
gene	NULL
insertion	NULL
could	NULL
,	NULL
however	NULL
,	NULL
disrupt	NULL
the	NULL
reg-	NULL
A	NULL
RNA-FISH	NULL
intron	NULL
probes	NULL
--	NULL
-	NULL
#	NULL
pre-mRNA	NULL
/	NULL
41	NULL
Â£1	NULL
f*	NULL
2	NULL
{	NULL
3	NULL
&	NULL
&	NULL
5Â°	NULL
PaxS	NULL
gene	NULL
polyA	NULL
\	NULL
allele	NULL
2	NULL
|	NULL
nucleus	NULL
allele	NULL
1	NULL
o	NULL
%	NULL
.	NULL

/	NULL
monoallelic	NULL
-	NULL
biallelic	NULL
Monoallelic	NULL
Transcription	NULL
of	NULL
Pax	NULL
Genes	NULL
-	NULL
605	NULL
ulation	NULL
of	NULL
the	NULL
targeted	NULL
Pax5	NULL
locus	NULL
itself	NULL
.	NULL

Indeed	NULL
,	NULL
different	NULL
locus-specific	NULL
effects	NULL
were	NULL
observed	NULL
in	NULL
lymphoid	NULL
cells	NULL
,	NULL
whenever	NULL
regulatory	NULL
regions	NULL
of	NULL
the	NULL
immunoglobulin	NULL
igHor	NULL
IgL	NULL
genes	NULL
were	NULL
inactivated	NULL
either	NULL
by	NULL
insertion	NULL
of	NULL
a	NULL
neomycin	NULL
gene	NULL
or	NULL
by	NULL
'clean	NULL
'	NULL
deletion	NULL
using	NULL
the	NULL
Cre-loxP	NULL
system	NULL
(	NULL
Gorman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

To	NULL
unequivocally	NULL
prove	NULL
the	NULL
monoallelic	NULL
expression	NULL
hy-pothesis	NULL
,	NULL
it	NULL
is	NULL
therefore	NULL
important	NULL
to	NULL
confirm	NULL
the	NULL
data	NULL
obtained	NULL
with	NULL
the	NULL
heterozygous	NULL
mouse	NULL
by	NULL
analyzing	NULL
PaxS5	NULL
expression	NULL
in	NULL
genetically	NULL
unmanipulated	NULL
B	NULL
cells	NULL
containing	NULL
two	NULL
equivalent	NULL
wild-type	NULL
PaxS5	NULL
alleles	NULL
.	NULL

Two	NULL
techniques	NULL
are	NULL
currently	NULL
available	NULL
to	NULL
detect	NULL
the	NULL
expression	NULL
of	NULL
wild-type	NULL
alleles	NULL
at	NULL
the	NULL
single-cell	NULL
level	NULL
.	NULL

Below	NULL
we	NULL
will	NULL
briefly	NULL
describe	NULL
the	NULL
two	NULL
methods	NULL
and	NULL
their	NULL
results	NULL
which	NULL
provided	NULL
further	NULL
support	NULL
for	NULL
monallelic	NULL
expression	NULL
of	NULL
Pax5	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

...	NULL
by	NULL
RNA-FISH	NULL
The	NULL
RNA-FISH	NULL
method	NULL
allows	NULL
the	NULL
detection	NULL
of	NULL
nascent	NULL
primary	NULL
transcripts	NULL
at	NULL
their	NULL
site	NULL
of	NULL
synthesis	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Forthis	NULL
purpose	NULL
,	NULL
biotinylated	NULL
DNA	NULL
probes	NULL
derived	NULL
from	NULL
in-trons	NULL
of	NULL
the	NULL
gene	NULL
of	NULL
interest	NULL
are	NULL
hybridized	NULL
to	NULL
non-dena-tured	NULL
nuclei	NULL
,	NULL
and	NULL
the	NULL
hybridization	NULL
signal	NULL
is	NULL
subsequently	NULL
amplified	NULL
by	NULL
incubation	NULL
with	NULL
fluorescently	NULL
labelled	NULL
avidin	NULL
(	NULL
Johnson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Panning	NULL
and	NULL
Jaenisch	NULL
,	NULL
1996	NULL
)	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

As	NULL
non-spliced	NULL
pre-mRNA	NULL
is	NULL
primarily	NULL
found	NULL
at	NULL
the	NULL
site	NULL
of	NULL
RNA	NULL
synthesis	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
each	NULL
actively	NULL
transcribing	NULL
allele	NULL
is	NULL
revealed	NULL
as	NULL
a	NULL
single	NULL
signal	NULL
(	NULL
dot	NULL
)	NULL
by	NULL
the	NULL
use	NULL
of	NULL
intron-specific	NULL
probes	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

One	NULL
dot	NULL
per	NULL
nucleus	NULL
identifies	NULL
a	NULL
monoallelically	NULL
transcribing	NULL
cell	NULL
,	NULL
while	NULL
two	NULL
dots	NULL
B	NULL
single-cell	NULL
RT-PCR	NULL
Bn	NULL
hybrid	NULL
|	NULL
sorting	NULL
of	NULL
individual	NULL
B	NULL
cells	NULL
}	NULL
reserve	NULL
transcription	NULL
||	NULL
with	NULL
primers	NULL
for	NULL
several	NULL
1	NULL
%	NULL
PCR	NULL
amplification	NULL
genes	NULL
2	NULL
``	NULL
``	NULL
PCR	NULL
with	NULL
gene-specific	NULL
primers	NULL
detection	NULL
of	NULL
polymorphism	NULL
Fig	NULL
.	NULL

3	NULL
-	NULL
Experimental	NULL
Strategies	NULL
for	NULL
Demonstrating	NULL
Monoallelic	NULL
Expression	NULL
in	NULL
Single	NULL
Cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
diagram	NULL
of	NULL
the	NULL
RNA-FISH	NULL
method	NULL
with	NULL
representative	NULL
examples	NULL
of	NULL
quiescent	NULL
splenocytes	NULL
expressing	NULL
PaxS5	NULL
mono-	NULL
or	NULL
bial-lelically	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Flow	NULL
diagram	NULL
of	NULL
the	NULL
single-cell	NULL
RT-PCR	NULL
technique	NULL
used	NULL
to	NULL
demonstrate	NULL
monoallelic	NULL
expression	NULL
of	NULL
PaxS	NULL
in	NULL
wild-type	NULL
B	NULL
cells	NULL
of	NULL
the	NULL
spleen	NULL
.	NULL

Unauthenticated	NULL
Download	NULL
Date	NULL
|	NULL
5/10/19	NULL
9:50	NULL
PM	NULL
606	NULL
-	NULL
S.L	NULL
.	NULL

Nutt	NULL
etal	NULL
.	NULL

are	NULL
characteristic	NULL
of	NULL
biallelic	NULL
transcription	NULL
in	NULL
a	NULL
quiescent	NULL
or	NULL
G1	NULL
cell	NULL
.	NULL

This	NULL
technique	NULL
has	NULL
been	NULL
successfully	NULL
used	NULL
to	NULL
visualize	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
globin	NULL
genes	NULL
in	NULL
ery-throid	NULL
precursor	NULL
cells	NULL
(	NULL
Wijgerde	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
and	NULL
to	NULL
follow	NULL
the	NULL
establishment	NULL
of	NULL
monoallelic	NULL
transcription	NULL
of	NULL
the	NULL
Xist	NULL
gene	NULL
during	NULL
X	NULL
chromosome	NULL
inactivation	NULL
(	NULL
Panning	NULL
and	NULL
Jaenisch	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
adapted	NULL
the	NULL
RNA-	NULL
FISH	NULL
technique	NULL
to	NULL
study	NULL
the	NULL
transcription	NULL
pattern	NULL
of	NULL
Pax5	NULL
in	NULL
B	NULL
cells	NULL
from	NULL
the	NULL
spleen	NULL
of	NULL
wild-type	NULL
mice	NULL
(	NULL
Nutt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

The	NULL
Pax5	NULL
mRNA	NULL
is	NULL
expressed	NULL
at	NULL
low	NULL
abundance	NULL
in	NULL
splenic	NULL
B	NULL
cells	NULL
(	NULL
see	NULL
below	NULL
)	NULL
,	NULL
and	NULL
hence	NULL
detection	NULL
of	NULL
primary	NULL
Pax5	NULL
transcripts	NULL
by	NULL
RNA-FISH	NULL
is	NULL
not	NULL
trivial	NULL
.	NULL

Consequently	NULL
,	NULL
the	NULL
RNA-FISH	NULL
experiments	NULL
had	NULL
to	NULL
be	NULL
carefully	NULL
controlled	NULL
in	NULL
order	NULL
to	NULL
avoid	NULL
misinterpretation	NULL
of	NULL
the	NULL
data	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
inefficient	NULL
hybridization	NULL
would	NULL
inadvertently	NULL
generate	NULL
monoallelic	NULL
expression	NULL
data	NULL
,	NULL
as	NULL
even	NULL
potentially	NULL
biallelic	NULL
cells	NULL
may	NULL
appear	NULL
monoallelic	NULL
.	NULL

To	NULL
estimate	NULL
the	NULL
efficiency	NULL
of	NULL
hybridization	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
frequency	NULL
of	NULL
cells	NULL
lacking	NULL
any	NULL
Pax5	NULL
RNA	NULL
signal	NULL
,	NULL
which	NULL
ideally	NULL
should	NULL
be	NULL
equivalent	NULL
to	NULL
the	NULL
percentage	NULL
of	NULL
dead	NULL
cells	NULL
measured	NULL
in	NULL
the	NULL
cell	NULL
population	NULL
at	NULL
the	NULL
onset	NULL
of	NULL
RNA	NULL
analysis	NULL
.	NULL

The	NULL
hybridization	NULL
efficiency	NULL
was	NULL
thus	NULL
assumed	NULL
to	NULL
be	NULL
close	NULL
to	NULL
100	NULL
%	NULL
,	NULL
if	NULL
every	NULL
live	NULL
cell	NULL
gave	NULL
rise	NULL
to	NULL
at	NULL
least	NULL
one	NULL
RNA	NULL
signal	NULL
.	NULL

Only	NULL
the	NULL
data	NULL
of	NULL
RNA-FISH	NULL
experiments	NULL
fulfilling	NULL
this	NULL
criterion	NULL
were	NULL
interpreted	NULL
.	NULL

To	NULL
further	NULL
assess	NULL
the	NULL
hybridization	NULL
conditions	NULL
,	NULL
we	NULL
performed	NULL
the	NULL
same	NULL
RNA-	NULL
FISH	NULL
analysis	NULL
with	NULL
a	NULL
second	NULL
transcription	NULL
factor	NULL
gene	NULL
,	NULL
Ikaros	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
in	NULL
lymphocytes	NULL
at	NULL
a	NULL
similarly	NULL
low	NULL
level	NULL
as	NULL
Pax5	NULL
(	NULL
Georgopou-los	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
Ikaros	NULL
probe	NULL
detected	NULL
2-4	NULL
RNA	NULL
signals	NULL
at	NULL
a	NULL
high	NULL
frequency	NULL
(	NULL
91	NULL
%	NULL
)	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
indicating	NULL
that	NULL
Ikaros	NULL
is	NULL
a	NULL
biallelically	NULL
transcribed	NULL
gene	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
monoallelic	NULL
Pax5	NULL
expression	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
majority	NULL
(	NULL
72	NULL
%	NULL
)	NULL
of	NULL
the	NULL
same	NULL
splenic	NULL
B	NULL
cells	NULL
.	NULL

A	NULL
similar	NULL
proportion	NULL
(	NULL
~75	NULL
%	NULL
)	NULL
of	NULL
monoallelically	NULL
transcribing	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
monitoring	NULL
CD19	NULL
and	NULL
lacZ	NULL
expression	NULL
in	NULL
the	NULL
heterozygous	NULL
Pax5	NULL
(	NULL
+/-	NULL
)	NULL
spleen	NULL
which	NULL
normally	NULL
contains	NULL
fewer	NULL
(	NULL
~25	NULL
%	NULL
)	NULL
immature	NULL
B	NULL
cells	NULL
(	NULL
biallelic	NULL
)	NULL
and	NULL
more	NULL
(	NULL
~75	NULL
%	NULL
)	NULL
mature	NULL
B	NULL
cells	NULL
(	NULL
monoallelic	NULL
)	NULL
(	NULL
Nutt	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
the	NULL
RNA-FISH	NULL
experiments	NULL
demonstrated	NULL
that	NULL
Pax5	NULL
is	NULL
subject	NULL
to	NULL
allele-specific	NULL
regulation	NULL
in	NULL
genetically	NULL
unmanipulated	NULL
B	NULL
cells	NULL
.	NULL

...	NULL
by	NULL
Single-	NULL
Cell	NULL
RT-PCR	NULL
Analysis	NULL
The	NULL
expression	NULL
of	NULL
a	NULL
given	NULL
gene	NULL
can	NULL
also	NULL
be	NULL
studied	NULL
at	NULL
the	NULL
single	NULL
cell	NULL
level	NULL
by	NULL
a	NULL
modified	NULL
two-step	NULL
RT-PCR	NULL
protocol	NULL
(	NULL
Hu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

This	NULL
technique	NULL
can	NULL
even	NULL
be	NULL
used	NULL
to	NULL
discriminate	NULL
between	NULL
the	NULL
expression	NULL
of	NULL
individual	NULL
polymorphic	NULL
alleles	NULL
in	NULL
a	NULL
single	NULL
cell	NULL
.	NULL

Indeed	NULL
,	NULL
single-cell	NULL
RT-PCR	NULL
analyses	NULL
have	NULL
been	NULL
successfully	NULL
utilized	NULL
to	NULL
demonstrate	NULL
monoallelic	NULL
transcription	NULL
of	NULL
the	NULL
odorant	NULL
receptor	NULL
genes	NULL
in	NULL
olfactory	NULL
neurons	NULL
(	NULL
Chess	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
and	NULL
of	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
genes	NULL
in	NULL
T	NULL
lymphocytes	NULL
(	NULL
Hollander	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Bix	NULL
and	NULL
Locksley	NULL
,	NULL
1998	NULL
)	NULL
.	NULL

We	NULL
also	NULL
employed	NULL
this	NULL
technique	NULL
to	NULL
investigate	NULL
the	NULL
allele-specific	NULL
regulation	NULL
of	NULL
Pax5	NULL
in	NULL
wild-type	NULL
B	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
analyze	NULL
expression	NULL
of	NULL
CD19	NULL
as	NULL
a	NULL
biallelic	NULL
control	NULL
gene	NULL
in	NULL
the	NULL
same	NULL
RT-PCR	NULL
experiments	NULL
.	NULL

As	NULL
shown	NULL
by	NULL
the	NULL
RNase	NULL
protection	NULL
analysis	NULL
in	NULL
Figure	NULL
4A	NULL
,	NULL
the	NULL
PaxS5and	NULL
CD19genes	NULL
are	NULL
expressed	NULL
at	NULL
similar	NULL
levels	NULL
in	NULL
pro-B	NULL
and	NULL
mature	NULL
B	NULL
cells	NULL
.	NULL

Quantification	NULL
of	NULL
the	NULL
RNase-protected	NULL
signals	NULL
revealed	NULL
that	NULL
a	NULL
single	NULL
splenic	NULL
B	NULL
cell	NULL
contains	NULL
as	NULL
little	NULL
as	NULL
30	NULL
and	NULL
80	NULL
molecules	NULL
of	NULL
Pax5	NULL
and	NULL
CD19	NULL
mRNA	NULL
,	NULL
respectively	NULL
(	NULL
Figure	NULL
4B	NULL
;	NULL
see	NULL
also	NULL
legend	NULL
)	NULL
.	NULL

Hence	NULL
it	NULL
became	NULL
apparent	NULL
that	NULL
the	NULL
reverse	NULL
transcriptase	NULL
reaction	NULL
had	NULL
to	NULL
be	NULL
quite	NULL
efficient	NULL
to	NULL
ensure	NULL
the	NULL
synthesis	NULL
of	NULL
several	NULL
cDNA	NULL
transcripts	NULL
starting	NULL
with	NULL
so	NULL
few	NULL
mRNA	NULL
templates	NULL
in	NULL
a	NULL
single	NULL
cell	NULL
.	NULL

To	NULL
be	NULL
able	NULL
to	NULL
discriminate	NULL
between	NULL
transcribed	NULL
alleles	NULL
,	NULL
we	NULL
have	NULL
searched	NULL
for	NULL
sequence	NULL
polymorphisms	NULL
in	NULL
the	NULL
CD19	NULL
and	NULL
Pax5	NULL
mRNA	NULL
of	NULL
two	NULL
related	NULL
subspecies	NULL
of	NULL
the	NULL
mouse	NULL
,	NULL
i.e	NULL
.	NULL

in	NULL
the	NULL
laboratory	NULL
strain	NULL
C3H	NULL
and	NULL
in	NULL
the	NULL
Mus	NULL
musculus	NULL
strain	NULL
PWD	NULL
(	NULL
Forejt	NULL
and	NULL
Gregorova	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

cDNA	NULL
cloning	NULL
and	NULL
sequence	NULL
analysis	NULL
revealed	NULL
a	NULL
cluster	NULL
of	NULL
changes	NULL
in	NULL
the	NULL
3	NULL
'	NULL
non-coding	NULL
region	NULL
of	NULL
Pax5	NULL
,	NULL
which	NULL
were	NULL
used	NULL
to	NULL
generate	NULL
PWD-	NULL
and	NULL
C3H-specific	NULL
oligonucleotide	NULL
probes	NULL
(	NULL
Figure	NULL
5A	NULL
)	NULL
.	NULL

cDNA	NULL
products	NULL
amplified	NULL
from	NULL
B	NULL
cells	NULL
of	NULL
the	NULL
PWD	NULL
and	NULL
C3H	NULL
strains	NULL
could	NULL
be	NULL
readily	NULL
distinguished	NULL
by	NULL
stringent	NULL
hybridization	NULL
with	NULL
these	NULL
probes	NULL
(	NULL
Figure	NULL
5B	NULL
)	NULL
.	NULL

The	NULL
coding	NULL
region	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
was	NULL
furthermore	NULL
shown	NULL
to	NULL
differ	NULL
at	NULL
position	NULL
665	NULL
by	NULL
a	NULL
C-to-T	NULL
transition	NULL
,	NULL
which	NULL
generated	NULL
a	NULL
Bgill	NULL
restriction	NULL
site	NULL
in	NULL
the	NULL
PWD	NULL
sequence	NULL
(	NULL
Figure	NULL
5C	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
Bgill	NULL
digestion	NULL
could	NULL
be	NULL
conveniently	NULL
used	NULL
to	NULL
discriminate	NULL
between	NULL
the	NULL
two	NULL
allelic	NULL
CD19	NULL
transcripts	NULL
that	NULL
were	NULL
amplified	NULL
from	NULL
B	NULL
cells	NULL
of	NULL
F1	NULL
(	NULL
C3H	NULL
x	NULL
PWD	NULL
)	NULL
hybrid	NULL
mice	NULL
(	NULL
Figure	NULL
5D	NULL
)	NULL
.	NULL

The	NULL
two-step	NULL
PCR	NULL
protocol	NULL
,	NULL
which	NULL
relies	NULL
on	NULL
the	NULL
use	NULL
of	NULL
nested	NULL
oligonucleotide	NULL
primers	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
,	NULL
is	NULL
extremely	NULL
sensitive	NULL
,	NULL
as	NULL
it	NULL
can	NULL
detect	NULL
a	NULL
single	NULL
cDNA	NULL
molecule	NULL
present	NULL
in	NULL
the	NULL
initial	NULL
RT	NULL
reaction	NULL
.	NULL

Hence	NULL
,	NULL
a	NULL
critical	NULL
parameter	NULL
of	NULL
the	NULL
single-cell	NULL
RT-PCR	NULL
experiment	NULL
is	NULL
the	NULL
number	NULL
of	NULL
cDNA	NULL
A	NULL
pro-B	NULL
B220+	NULL
calls	NULL
-	NULL
splenocytes	NULL
--	NULL
-I	NULL
t-	NULL
1	NULL
Pax5	NULL
Â«	NULL
-	NULL
aam	NULL
o	NULL
C19	NULL
-	NULL
wees	NULL
enee	NULL
Â«	NULL
we	NULL
wat	NULL
-	NULL
>	NULL
>	NULL
B	NULL
mRNA	NULL
molecules	NULL
/	NULL
cell	NULL
o	NULL
--	NULL
a	NULL
Fag	NULL
:	NULL
CD19	NULL
pro-B	NULL
cell	NULL
30	NULL
30	NULL
splenic	NULL
B	NULL
cell	NULL
30	NULL
80	NULL
Fig	NULL
.	NULL

4	NULL
-	NULL
Quantitation	NULL
of	NULL
the	NULL
Pax5	NULL
and	NULL
CD19	NULL
mRNA	NULL
Molecules	NULL
Present	NULL
in	NULL
a	NULL
Single	NULL
B	NULL
Lymphocyte	NULL
.	NULL

(	NULL
A	NULL
)	NULL
RNase	NULL
protection	NULL
analysis	NULL
.	NULL

CD19	NULL
and	NULL
Pax5	NULL
mRNA	NULL
levels	NULL
were	NULL
quantitated	NULL
by	NULL
RNase	NULL
protection	NULL
assay	NULL
in	NULL
total	NULL
RNA	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
prepared	NULL
from	NULL
B220*	NULL
sorted	NULL
splenocytes	NULL
and	NULL
in	NULL
vifro	NULL
cultured	NULL
pro-B	NULL
cells	NULL
.	NULL

The	NULL
size	NULL
of	NULL
the	NULL
RNase-protected	NULL
signal	NULL
is	NULL
indicated	NULL
in	NULL
nu-cleotides	NULL
to	NULL
the	NULL
right	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Quantitation	NULL
of	NULL
the	NULL
RNase	NULL
protection	NULL
data	NULL
.	NULL

The	NULL
number	NULL
of	NULL
mRNA	NULL
molecules	NULL
per	NULL
B	NULL
lymphocyte	NULL
was	NULL
calculated	NULL
from	NULL
the	NULL
known	NULL
number	NULL
of	NULL
B	NULL
cells	NULL
required	NULL
to	NULL
obtain	NULL
10	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
,	NULL
the	NULL
specific	NULL
activity	NULL
of	NULL
each	NULL
riboprobe	NULL
and	NULL
the	NULL
radioactivity	NULL
present	NULL
in	NULL
the	NULL
RNase-protected	NULL
signals	NULL
(	NULL
measured	NULL
by	NULL
phosphorimager	NULL
analysis	NULL
)	NULL
.	NULL

Unauthenticated	NULL
Download	NULL
Date	NULL
|	NULL
5/10/19	NULL
9:50	NULL
PM	NULL
Monoallelic	NULL
Transcription	NULL
of	NULL
Pax	NULL
Genes	NULL
-	NULL
607	NULL
mPax5	NULL
a	NULL
probe	NULL
&	NULL
a	NULL
FoI	NULL
s	NULL
comme	NULL
-	NULL
wifie	NULL
a	NULL
common	NULL
|	NULL
PWD	NULL
C3H	NULL
``	NULL
a	NULL
[	NULL
b	NULL
comman	NULL
*	NULL
specific	NULL
$	NULL
07	NULL
-t	NULL
-+	NULL
M	NULL
___I	NULL
.	NULL

z	NULL
â|â_	NULL
--	NULL
Pu	NULL
â	NULL
.	NULL
'	NULL

j	NULL
I	NULL
I	NULL
cDNA	NULL
scams	NULL
am	NULL
|-	NULL
C3-mcDig	NULL
8g	NULL
!	NULL

!	NULL

!	NULL

I	NULL
mlEr	NULL
.	NULL

â	NULL
PWD	NULL
$	NULL
u	NULL
a	NULL
Bgl	NULL
II	NULL
caer	NULL
caH	NULL
g	NULL
-+	NULL
-+	NULL
_	NULL
fl	NULL
$	NULL
1Y	NULL
565	NULL
6	NULL
*e	NULL
%	NULL
~=	NULL
a-	NULL
423	NULL
bp	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
Â»	NULL
input	NULL
*	NULL
--	NULL
128	NULL
--	NULL
Â»	NULL
Â«	NULL
Â«	NULL
-	NULL
103	NULL
-	NULL
>	NULL
197	NULL
--	NULL
-+	NULL
Pwp	NULL
E	NULL
___	NULL
ONA	NULL
input	NULL
a-	NULL
123	NULL
300	NULL
C3H	NULL
M	NULL
``	NULL
tw	NULL
~C3H	NULL
-PWD	NULL
Fig	NULL
.	NULL

5	NULL
-	NULL
Identification	NULL
of	NULL
Nucleotide	NULL
Polymorphisms	NULL
in	NULL
PaxS	NULL
and	NULL
CD19	NULL
mRNAs	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nucleotide	NULL
polymorphisms	NULL
were	NULL
identified	NULL
in	NULL
the	NULL
3	NULL
'	NULL
non-coding	NULL
sequence	NULL
of	NULL
PaxS	NULL
exon	NULL
10	NULL
by	NULL
RT-PCR	NULL
amplification	NULL
and	NULL
sequencing	NULL
of	NULL
a	NULL
332-bp	NULL
cDNA	NULL
fragment	NULL
from	NULL
the	NULL
spleen	NULL
of	NULL
C3H	NULL
and	NULL
PWD	NULL
mice	NULL
.	NULL

Nucleotide	NULL
positions	NULL
correspond	NULL
to	NULL
the	NULL
published	NULL
mouse	NULL
PaxS5	NULL
cDNA	NULL
sequence	NULL
(	NULL
Adams	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
and	NULL
arrowheads	NULL
denote	NULL
the	NULL
positions	NULL
of	NULL
introns	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
oligonucleotide	NULL
probes	NULL
shown	NULL
by	NULL
brackets	NULL
in	NULL
(	NULL
A	NULL
)	NULL
were	NULL
used	NULL
for	NULL
high-stringency	NULL
slot-blot	NULL
hybridization	NULL
of	NULL
Pax5	NULL
PCR	NULL
products	NULL
which	NULL
were	NULL
amplified	NULL
from	NULL
B	NULL
cells	NULL
of	NULL
PWD	NULL
and	NULL
C3H	NULL
mice	NULL
.	NULL

(	NULL
C	NULL
)	NULL
A	NULL
polymorphic	NULL
Bg/ll	NULL
restriction	NULL
site	NULL
in	NULL
the	NULL
coding	NULL
region	NULL
of	NULL
CD19	NULL
(	NULL
Zhou	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
facilitates	NULL
rapid	NULL
determination	NULL
of	NULL
the	NULL
allelic	NULL
origin	NULL
of	NULL
CD19	NULL
transcripts	NULL
by	NULL
Bgill	NULL
digestion	NULL
.	NULL

The	NULL
sizes	NULL
of	NULL
the	NULL
PCR	NULL
product	NULL
and	NULL
its	NULL
Bg/ll	NULL
restriction	NULL
fragments	NULL
are	NULL
indicated	NULL
in	NULL
base	NULL
pairs	NULL
(	NULL
bp	NULL
)	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Bgill	NULL
digestion	NULL
of	NULL
CD19	NULL
PCR	NULL
fragments	NULL
amplified	NULL
from	NULL
the	NULL
spleen	NULL
of	NULL
PWD	NULL
,	NULL
C3H	NULL
and	NULL
F1	NULL
(	NULL
PWD	NULL
x	NULL
C3H	NULL
)	NULL
hybrid	NULL
mice	NULL
.	NULL

(	NULL
E	NULL
)	NULL
Unbiased	NULL
PCR	NULL
amplification	NULL
of	NULL
the	NULL
polymorphic	NULL
CD19	NULL
transcripts	NULL
.	NULL

CD19	NULL
cDNA	NULL
(	NULL
100	NULL
ng	NULL
)	NULL
derived	NULL
from	NULL
the	NULL
PWD	NULL
and	NULL
C3H	NULL
parental	NULL
strains	NULL
was	NULL
mixed	NULL
,	NULL
serially	NULL
diluted	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
the	NULL
2-step	NULL
PCR	NULL
regimen	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Figure	NULL
6	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
digested	NULL
with	NULL
Bgi/ll	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
1.5	NULL
%	NULL
agarose	NULL
gel	NULL
.	NULL

Methods	NULL
:	NULL
F1	NULL
hybrid	NULL
off-spring	NULL
was	NULL
obtained	NULL
by	NULL
intercrossing	NULL
mice	NULL
of	NULL
the	NULL
Mus	NULL
musculus	NULL
inbred	NULL
strain	NULL
PWD	NULL
(	NULL
Forejt	NULL
and	NULL
Gregorova	NULL
,	NULL
1992	NULL
)	NULL
and	NULL
the	NULL
inbred	NULL
laboratory	NULL
strain	NULL
C3H	NULL
.	NULL

The	NULL
following	NULL
oligonucleotides	NULL
were	NULL
used	NULL
for	NULL
single-cell	NULL
RT-PCR	NULL
analysis	NULL
.	NULL

mouse	NULL
Pax5	NULL
:	NULL
(	NULL
a	NULL
)	NULL
5-CCTACCCTAT	NULL
TGTCACAGGCC-3	NULL
``	NULL
;	NULL
(	NULL
B	NULL
)	NULL
5'-GAGACT	NULL
TGGCGAGCACAACC-3	NULL
``	NULL
;	NULL
(	NULL
y	NULL
)	NULL
5-CCTCTGTCTGTCTCAGGGGGTT3	NULL
'	NULL
;	NULL
(	NULL
86	NULL
)	NULL
5'-TCAGGGGTTGGGAGGCTGCC-3	NULL
'	NULL
.	NULL

mouse	NULL
CD19	NULL
;	NULL
(	NULL
Â«	NULL
)	NULL
5'-TGGAATGCT	NULL
TCAGACGTCAGG-3	NULL
'	NULL
;	NULL
(	NULL
B	NULL
)	NULL
5-CCACAGGTCCACTTCTGGTTC-3	NULL
``	NULL
;	NULL
(	NULL
y	NULL
)	NULL
5'-AAGTCACCACTGGGACTATCC-3	NULL
'	NULL
;	NULL
(	NULL
8	NULL
)	NULL
5'-CTCAACAGCCAGAGCCACACT-3	NULL
'	NULL
.	NULL

Discrimination	NULL
of	NULL
polymorphic	NULL
PaxS	NULL
and	NULL
CD19tran-scripts	NULL
:	NULL
the	NULL
allelic	NULL
origin	NULL
of	NULL
the	NULL
CD19	NULL
PCR	NULL
product	NULL
was	NULL
determined	NULL
by	NULL
Bgill	NULL
digestion	NULL
followed	NULL
by	NULL
gel	NULL
electrophoretic	NULL
analysis	NULL
.	NULL

Approximately	NULL
100	NULL
ng	NULL
of	NULL
the	NULL
Pax5	NULL
PCR	NULL
product	NULL
was	NULL
denatured	NULL
by	NULL
dilution	NULL
in	NULL
0.41	NULL
NaOH	NULL
and	NULL
heating	NULL
to	NULL
100	NULL
Â°C	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
denatured	NULL
DNA	NULL
fragments	NULL
were	NULL
then	NULL
slot-	NULL
blotted	NULL
onto	NULL
nylon	NULL
membranes	NULL
and	NULL
hybridized	NULL
to	NULL
end-labeled	NULL
allele-specific	NULL
or	NULL
common	NULL
PaxS	NULL
oligonucleotides	NULL
(	NULL
see	NULL
panel	NULL
A	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
allele	NULL
detection	NULL
was	NULL
achieved	NULL
by	NULL
overnight	NULL
hybridization	NULL
in	NULL
10	NULL
%	NULL
formamide	NULL
/	NULL
6	NULL
%	NULL
SSC	NULL
at	NULL
50Â°C	NULL
,	NULL
which	NULL
corresponds	NULL
to	NULL
2-5Â°C	NULL
below	NULL
the	NULL
predicted	NULL
DNA	NULL
melting	NULL
temperature	NULL
of	NULL
the	NULL
respective	NULL
double-stranded	NULL
oligonucleotides	NULL
.	NULL

Blots	NULL
were	NULL
washed	NULL
in	NULL
1	NULL
X	NULL
SSC	NULL
at	NULL
60Â°C	NULL
and	NULL
exposed	NULL
to	NULL
X-ray	NULL
film	NULL
for	NULL
~	NULL
1	NULL
h	NULL
at	NULL
-70	NULL
Â°C	NULL
.	NULL

transcripts	NULL
which	NULL
are	NULL
synthesized	NULL
by	NULL
reverse	NULL
transcriptase	NULL
prior	NULL
to	NULL
exponential	NULL
amplification	NULL
.	NULL

Inefficient	NULL
cDNA	NULL
synthesis	NULL
may	NULL
generate	NULL
only	NULL
one	NULL
cDNA	NULL
transcript	NULL
even	NULL
from	NULL
biallelically	NULL
transcribing	NULL
cells	NULL
,	NULL
thus	NULL
creating	NULL
an	NULL
arti-fact	NULL
,	NULL
as	NULL
every	NULL
gene	NULL
examined	NULL
would	NULL
appear	NULL
to	NULL
be	NULL
monoallelically	NULL
expressed	NULL
.	NULL

Using	NULL
CD19	NULL
mRNA	NULL
as	NULL
a	NULL
template	NULL
,	NULL
we	NULL
optimized	NULL
several	NULL
paramaters	NULL
of	NULL
the	NULL
single-cell	NULL
RT-PCR	NULL
assay	NULL
to	NULL
achieve	NULL
the	NULL
desired	NULL
goal	NULL
of	NULL
amplifying	NULL
both	NULL
allelic	NULL
transcripts	NULL
from	NULL
a	NULL
single	NULL
B	NULL
cell	NULL
of	NULL
an	NULL
F1	NULL
hybrid	NULL
mouse	NULL
(	NULL
for	NULL
details	NULL
see	NULL
legend	NULL
to	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
two	NULL
modifications	NULL
proved	NULL
to	NULL
be	NULL
crucial	NULL
,	NULL
as	NULL
they	NULL
increased	NULL
the	NULL
number	NULL
of	NULL
positive	NULL
cells	NULL
up	NULL
to	NULL
95	NULL
%	NULL
and	NULL
allowed	NULL
the	NULL
detection	NULL
of	NULL
both	NULL
allelic	NULL
CD19	NULL
transcripts	NULL
in	NULL
>	NULL
90	NULL
%	NULL
of	NULL
these	NULL
cells	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

First	NULL
,	NULL
the	NULL
use	NULL
of	NULL
gene-specific	NULL
oligonucleotides	NULL
as	NULL
opposed	NULL
to	NULL
random	NULL
hexamer	NULL
or	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
primers	NULL
led	NULL
to	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
the	NULL
number	NULL
of	NULL
cells	NULL
from	NULL
which	NULL
CD19transcripts	NULL
could	NULL
be	NULL
amplified	NULL
.	NULL

Second	NULL
,	NULL
RNase	NULL
H	NULL
digestion	NULL
of	NULL
the	NULL
RNA-DNA	NULL
hybrids	NULL
of	NULL
the	NULL
RT	NULL
reaction	NULL
considerably	NULL
improved	NULL
the	NULL
efficiency	NULL
of	NULL
PCRampli-fication	NULL
.	NULL

Importantly	NULL
,	NULL
the	NULL
two	NULL
CD19	NULL
transcripts	NULL
were	NULL
amplified	NULL
in	NULL
an	NULL
unbiased	NULL
manner	NULL
,	NULL
as	NULL
both	NULL
alleles	NULL
were	NULL
detected	NULL
with	NULL
equal	NULL
efficiency	NULL
upon	NULL
serial	NULL
dilution	NULL
of	NULL
a	NULL
corresponding	NULL
cDNA	NULL
mixture	NULL
(	NULL
Figure	NULL
5E	NULL
)	NULL
.	NULL

The	NULL
result	NULL
of	NULL
a	NULL
typical	NULL
single-cell	NULL
RT-PCR	NULL
experiment	NULL
,	NULL
which	NULL
was	NULL
performed	NULL
under	NULL
optimized	NULL
conditions	NULL
with	NULL
individual	NULL
B220*	NULL
Ig	NULL
M*	NULL
splenocytes	NULL
,	NULL
is	NULL
shown	NULL
in	NULL
Figure	NULL
6	NULL
.	NULL

Both	NULL
allelic	NULL
CD19	NULL
transcripts	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
cells	NULL
,	NULL
as	NULL
expected	NULL
for	NULL
a	NULL
biallelically	NULL
expressed	NULL
gene	NULL
.	NULL

However	NULL
,	NULL
only	NULL
38	NULL
%	NULL
of	NULL
the	NULL
CD19	NULL
biallelically	NULL
transcribing	NULL
cells	NULL
expressed	NULL
also	NULL
both	NULL
PaxS	NULL
alleles	NULL
(	NULL
Figure	NULL
6B	NULL
,	NULL
C	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
single-cell	NULL
RT-PCR	NULL
method	NULL
revealed	NULL
monoallelic	NULL
Pax5	NULL
expression	NULL
in	NULL
62	NULL
%	NULL
of	NULL
all	NULL
splenic	NULL
B	NULL
cells	NULL
which	NULL
is	NULL
in	NULL
good	NULL
agreement	NULL
with	NULL
the	NULL
RNA-FISH	NULL
data	NULL
(	NULL
72	NULL
%	NULL
)	NULL
and	NULL
flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
the	NULL
Pax5	NULL
(	NULL
+/-	NULL
)	NULL
mice	NULL
(	NULL
~75	NULL
%	NULL
)	NULL
Unauthenticated	NULL
Download	NULL
Date	NULL
|	NULL
5/10/19	NULL
9:50	NULL
PM	NULL
608	NULL
-	NULL
S.L	NULL
.	NULL

Nutt	NULL
etal	NULL
.	NULL

A	NULL
mcoig	NULL
B	NULL
M	NULL
OM	NULL
OB	NULL
B	NULL
M	NULL
B	NULL
M	NULL
M	NULL
OB	NULL
B	NULL
B	NULL
M	NULL
OB	NULL
OB	NULL
MOM	NULL
_	NULL
M	NULL
M	NULL
-	NULL
MOM	NULL
_	NULL
OM	NULL
-_	NULL
OM	NULL
OB	NULL
M	NULL
-	NULL
OM	NULL
OB	NULL
MOM	NULL
OB	NULL
M	NULL
-	NULL
M	NULL
C3H	NULL
PWD	NULL
C	NULL
PaxÂ§	NULL
cells	NULL
monoallelic	NULL
(	NULL
M	NULL
)	NULL
46	NULL
(	NULL
62	NULL
%	NULL
)	NULL
biallelic	NULL
(	NULL
B	NULL
)	NULL
29	NULL
(	NULL
38	NULL
%	NULL
)	NULL
Fig	NULL
.	NULL

6	NULL
-	NULL
Single-Cell	NULL
RT-PCR	NULL
Analysis	NULL
of	NULL
PaxS5	NULL
and	NULL
CD19	NULL
Expression	NULL
in	NULL
Splenic	NULL
B	NULL
Cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Biallelic	NULL
transcription	NULL
of	NULL
the	NULL
polymorphic	NULL
CD19	NULL
alleles	NULL
in	NULL
individual	NULL
B	NULL
cells	NULL
of	NULL
F1	NULL
(	NULL
PWD	NULL
X	NULL
C3H	NULL
)	NULL
hybrid	NULL
mice	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
of	NULL
PWD	NULL
and	NULL
C3H	NULL
origin	NULL
were	NULL
discriminated	NULL
by	NULL
Bgill	NULL
digestion	NULL
.	NULL

PCR	NULL
reactions	NULL
containing	NULL
only	NULL
one	NULL
of	NULL
the	NULL
two	NULL
allelic	NULL
CD19	NULL
transcripts	NULL
(	NULL
denoted	NULL
by	NULL
asterisks	NULL
)	NULL
were	NULL
excluded	NULL
from	NULL
further	NULL
analysis	NULL
of	NULL
PaxS5	NULL
expression	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Slot-blot	NULL
analysis	NULL
of	NULL
the	NULL
RT-PCR	NULL
reactions	NULL
of	NULL
32	NULL
individual	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
PCR	NULL
reactions	NULL
of	NULL
only	NULL
those	NULL
cells	NULL
which	NULL
were	NULL
determined	NULL
to	NULL
be	NULL
biallelic	NULL
for	NULL
CD19transcription	NULL
were	NULL
analyzed	NULL
by	NULL
slot-blot	NULL
hybridization	NULL
with	NULL
PWD-	NULL
and	NULL
C3H-specific	NULL
probes	NULL
(	NULL
see	NULL
legend	NULL
to	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

PaxS5	NULL
cDNA	NULL
derived	NULL
from	NULL
the	NULL
spleen	NULL
of	NULL
parental	NULL
PWD	NULL
and	NULL
C3H	NULL
mice	NULL
was	NULL
used	NULL
as	NULL
specificity	NULL
control	NULL
.	NULL

M	NULL
,	NULL
monoallelic	NULL
;	NULL
B	NULL
,	NULL
biallelic	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Summary	NULL
of	NULL
PaxS	NULL
transcription	NULL
in	NULL
75	NULL
individual	NULL
B	NULL
cells	NULL
which	NULL
were	NULL
all	NULL
shown	NULL
to	NULL
biallelically	NULL
express	NULL
CD19	NULL
.	NULL

Methods	NULL
:	NULL
Single-cell	NULL
RT-PCR	NULL
analysis	NULL
:	NULL
Single-cell	NULL
suspensions	NULL
prepared	NULL
from	NULL
the	NULL
spleen	NULL
of	NULL
4-6-week-old	NULL
F1	NULL
hybrid	NULL
mice	NULL
were	NULL
stained	NULL
with	NULL
phycoerythrin	NULL
(	NULL
PE	NULL
)	NULL
-conjugated	NULL
anti-igM	NULL
mAb	NULL
(	NULL
Im-munotech	NULL
)	NULL
and	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
conjugated	NULL
anti-	NULL
B220	NULL
mAb	NULL
(	NULL
RA3-6B2	NULL
,	NULL
PharMingen	NULL
)	NULL
.	NULL

Individual	NULL
B220*	NULL
Ig	NULL
M*	NULL
cells	NULL
were	NULL
sorted	NULL
with	NULL
a	NULL
FACS	NULL
Vantage	NULL
TSO	NULL
flow	NULL
cytometer	NULL
(	NULL
Bec-ton-	NULL
Dickinson	NULL
)	NULL
into	NULL
single	NULL
wells	NULL
of	NULL
a	NULL
96-well	NULL
PCR	NULL
plate	NULL
each	NULL
containing	NULL
5	NULL
wl	NULL
PBS	NULL
.	NULL

Plates	NULL
were	NULL
frozen	NULL
at	NULL
-70Â°C	NULL
until	NULL
further	NULL
use	NULL
.	NULL

Upon	NULL
thawing	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
heating	NULL
to	NULL
70Â°C	NULL
for	NULL
2	NULL
minutes	NULL
and	NULL
then	NULL
placed	NULL
on	NULL
ice	NULL
.	NULL

10	NULL
wl	NULL
of	NULL
the	NULL
reverse	NULL
transcriptase	NULL
(	NULL
RT	NULL
)	NULL
reaction	NULL
mixture	NULL
[	NULL
containing	NULL
1	NULL
mm	NULL
dNTP	NULL
,	NULL
10	NULL
mm	NULL
DTT	NULL
,	NULL
50	NULL
mm	NULL
Tris-HCI	NULL
pH	NULL
8.3	NULL
,	NULL
7.5	NULL
mm	NULL
KCI	NULL
,	NULL
3mm	NULL
MgCliz	NULL
,	NULL
5	NULL
ng/pwl	NULL
RT-primers	NULL
(	NULL
PaxS	NULL
and	NULL
CD19	NULL
oligonucleotides	NULL
y	NULL
)	NULL
,	NULL
60	NULL
U	NULL
SuperScript	NULL
``	NULL
II	NULL
(	NULL
GibcoBRL	NULL
)	NULL
and	NULL
30	NULL
U	NULL
RNasin	NULL
(	NULL
Promega	NULL
)	NULL
]	NULL
were	NULL
added	NULL
to	NULL
each	NULL
well	NULL
followed	NULL
by	NULL
in	NULL
(	NULL
Nutt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
three	NULL
fundamentally	NULL
different	NULL
methods	NULL
support	NULL
the	NULL
same	NULL
conclusion	NULL
that	NULL
Pax5	NULL
is	NULL
subject	NULL
to	NULL
allele-specific	NULL
regulation	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

Monoallelic	NULL
Expression	NULL
as	NULL
a	NULL
Result	NULL
of	NULL
Stochastic	NULL
Activation	NULL
of	NULL
Pax5	NULL
at	NULL
Lineage	NULL
Commitment	NULL
Pax5	NULL
is	NULL
the	NULL
first	NULL
transcription	NULL
factor	NULL
gene	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
predominantly	NULL
expressed	NULL
from	NULL
only	NULL
one	NULL
of	NULL
its	NULL
two	NULL
alleles	NULL
in	NULL
a	NULL
stochastic	NULL
and	NULL
reversible	NULL
manner	NULL
.	NULL

This	NULL
allele-specific	NULL
regulation	NULL
generates	NULL
a	NULL
haploinsufficient	NULL
phenotype	NULL
at	NULL
the	NULL
cellular	NULL
level	NULL
in	NULL
B-lymphoid	NULL
tissues	NULL
of	NULL
Pax5	NULL
(	NULL
+/-	NULL
)	NULL
mice	NULL
(	NULL
Nutt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

However	NULL
,	NULL
for	NULL
reasons	NULL
discussed	NULL
above	NULL
,	NULL
heterozygous	NULL
mutation	NULL
of	NULL
the	NULL
Pax5	NULL
gene	NULL
has	NULL
no	NULL
phenotypic	NULL
consequences	NULL
(	NULL
Urbanek	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
and	NULL
hence	NULL
does	NULL
not	NULL
provide	NULL
a	NULL
model	NULL
for	NULL
a	NULL
human	NULL
disease	NULL
syndrome	NULL
(	NULL
Vorechovsky	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
heterozygous	NULL
mutations	NULL
of	NULL
the	NULL
closely	NULL
related	NULL
PAX2	NULL
and	NULL
PAX8genes	NULL
of	NULL
the	NULL
same	NULL
Paxsubfamily	NULL
are	NULL
known	NULL
to	NULL
cause	NULL
the	NULL
renal-coloboma	NULL
syndrome	NULL
(	NULL
Sanyanusin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
and	NULL
congenital	NULL
hypothyroidism	NULL
(	NULL
Macchia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
allele-specific	NULL
transcriptional	NULL
regulation	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
susceptibility	NULL
of	NULL
these	NULL
and	NULL
other	NULL
mammalian	NULL
Paxgenes	NULL
to	NULL
single	NULL
mutations	NULL
.	NULL

A	NULL
model	NULL
of	NULL
stochastic	NULL
allele-specific	NULL
regulation	NULL
of	NULL
Pax	NULL
genes	NULL
could	NULL
account	NULL
for	NULL
two	NULL
aspects	NULL
of	NULL
Pax-related	NULL
disease	NULL
syndromes	NULL
;	NULL
i.e	NULL
.	NULL

their	NULL
phenotypic	NULL
variability	NULL
and	NULL
tissue	NULL
preference	NULL
.	NULL

The	NULL
severity	NULL
of	NULL
a	NULL
heterozygous	NULL
Pax	NULL
mutation	NULL
would	NULL
be	NULL
expected	NULL
to	NULL
depend	NULL
on	NULL
the	NULL
stochastically	NULL
determined	NULL
ratio	NULL
of	NULL
cells	NULL
activating	NULL
either	NULL
the	NULL
wild-type	NULL
or	NULL
mutant	NULL
allele	NULL
.	NULL

An	NULL
increased	NULL
frequency	NULL
(	NULL
>	NULL
50	NULL
%	NULL
)	NULL
of	NULL
cells	NULL
expressing	NULL
the	NULL
wild-type	NULL
allele	NULL
may	NULL
result	NULL
in	NULL
a	NULL
milder	NULL
phenotype	NULL
,	NULL
while	NULL
a	NULL
higher	NULL
proportion	NULL
(	NULL
>	NULL
50	NULL
%	NULL
)	NULL
of	NULL
cells	NULL
activating	NULL
the	NULL
mutant	NULL
allele	NULL
should	NULL
cause	NULL
a	NULL
more	NULL
severe	NULL
phenotype	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
independent	NULL
regulation	NULL
ofthe	NULL
two	NULL
PaxS5alleles	NULL
during	NULL
B	NULL
cell	NULL
development	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
suggests	NULL
that	NULL
other	NULL
Pax	NULL
genes	NULL
may	NULL
also	NULL
be	NULL
transcribed	NULL
monoallelically	NULL
in	NULL
some	NULL
tissues	NULL
and	NULL
biallelically	NULL
in	NULL
others	NULL
,	NULL
thus	NULL
explaining	NULL
why	NULL
haploinsufficient	NULL
phenotypes	NULL
are	NULL
observed	NULL
only	NULL
in	NULL
a	NULL
subset	NULL
of	NULL
the	NULL
Pax	NULL
expression	NULL
domains	NULL
cubation	NULL
at	NULL
42Â°C	NULL
for	NULL
1	NULL
h.	NULL
The	NULL
RT	NULL
reaction	NULL
was	NULL
stopped	NULL
by	NULL
heating	NULL
the	NULL
plate	NULL
to	NULL
70Â°C	NULL
for	NULL
10	NULL
min	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
0.5	NULL
U	NULL
RNase	NULL
H	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
37Â°C	NULL
and	NULL
again	NULL
heating	NULL
to	NULL
70Â°C	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

76	NULL
wl	NULL
of	NULL
the	NULL
PCR	NULL
mixture	NULL
[	NULL
1	NULL
x	NULL
PCR	NULL
buffer	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
containing	NULL
0.8	NULL
mm	NULL
dNTPs	NULL
,	NULL
0.75	NULL
pg	NULL
of	NULL
the	NULL
PaxS5	NULL
and	NULL
CD19	NULL
PCR	NULL
primers	NULL
Â«	NULL
and	NULL
y	NULL
,	NULL
and	NULL
4U	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
]	NULL
were	NULL
then	NULL
added	NULL
to	NULL
the	NULL
RNase	NULL
H-treated	NULL
RT	NULL
reaction	NULL
followed	NULL
by	NULL
25	NULL
cycles	NULL
of	NULL
PCR	NULL
amplification	NULL
.	NULL

2	NULL
wl	NULL
of	NULL
the	NULL
first	NULL
PCR	NULL
reaction	NULL
was	NULL
then	NULL
used	NULL
for	NULL
separate	NULL
amplification	NULL
of	NULL
PaxS	NULL
and	NULL
CD19cDNA	NULL
by	NULL
utilizing	NULL
the	NULL
respective	NULL
nested	NULL
primer	NULL
combinations	NULL
B	NULL
and	NULL
8	NULL
for	NULL
additional	NULL
25	NULL
cycles	NULL
.	NULL

The	NULL
332-bp	NULL
PaxS5	NULL
and	NULL
423-bp	NULL
CD19	NULL
cDNA	NULL
fragments	NULL
could	NULL
be	NULL
readily	NULL
visualized	NULL
by	NULL
analyzing	NULL
20	NULL
wl	NULL
of	NULL
the	NULL
second	NULL
PCR	NULL
reaction	NULL
on	NULL
a	NULL
1.5	NULL
%	NULL
agarose	NULL
gel	NULL
.	NULL

Unauthenticated	NULL
Download	NULL
Date	NULL
|	NULL
5/10/19	NULL
9:50	NULL
PM	NULL
(	NULL
Strachan	NULL
and	NULL
Read	NULL
,	NULL
1994	NULL
;	NULL
Mansouri	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
is	NULL
worth	NULL
noting	NULL
that	NULL
switching	NULL
of	NULL
expression	NULL
between	NULL
alleles	NULL
may	NULL
be	NULL
deleterious	NULL
in	NULL
a	NULL
heterozygous	NULL
situation	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
a	NULL
cell	NULL
that	NULL
differentiates	NULL
along	NULL
a	NULL
particular	NULL
lineage	NULL
due	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
wild-type	NULL
Paxallele	NULL
,	NULL
may	NULL
lose	NULL
its	NULL
identity	NULL
and	NULL
possibly	NULL
die	NULL
upon	NULL
switching	NULL
to	NULL
expression	NULL
of	NULL
the	NULL
mutant	NULL
allele	NULL
.	NULL

Recently	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
Pax5	NULL
is	NULL
a	NULL
key	NULL
regulator	NULL
of	NULL
B-lineage	NULL
commitment	NULL
.	NULL

Early	NULL
pro-	NULL
B	NULL
cells	NULL
lacking	NULL
Pax5	NULL
function	NULL
are	NULL
able	NULL
to	NULL
differentiate	NULL
along	NULL
multiple	NULL
hematopoietic	NULL
lineages	NULL
,	NULL
but	NULL
are	NULL
entirely	NULL
blocked	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
proceed	NULL
along	NULL
the	NULL
B	NULL
cell	NULL
pathway	NULL
(	NULL
S.N	NULL
.	NULL

,	NULL
A.	NULL
Rolink	NULL
and	NULL
M.B	NULL
.	NULL

,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Monoallelic	NULL
transcription	NULL
of	NULL
Pax5	NULL
at	NULL
the	NULL
onset	NULL
of	NULL
B-lymphopoiesis	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
is	NULL
particularly	NULL
interesting	NULL
in	NULL
view	NULL
of	NULL
these	NULL
new	NULL
findings	NULL
.	NULL

Multipotent	NULL
progenitor	NULL
cells	NULL
are	NULL
characterized	NULL
by	NULL
their	NULL
ability	NULL
to	NULL
undergo	NULL
self-renewal	NULL
or	NULL
development	NULL
to	NULL
several	NULL
different	NULL
lineages	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

High-level	NULL
expression	NULL
of	NULL
a	NULL
lineage-determination	NULL
gene	NULL
like	NULL
Pax5	NULL
might	NULL
force	NULL
such	NULL
progenitor	NULL
cells	NULL
to	NULL
differentiate	NULL
along	NULL
a	NULL
single	NULL
lineage	NULL
and	NULL
could	NULL
thus	NULL
deprive	NULL
these	NULL
cells	NULL
of	NULL
their	NULL
various	NULL
options	NULL
.	NULL

The	NULL
multipotency	NULL
of	NULL
these	NULL
cells	NULL
could	NULL
,	NULL
however	NULL
,	NULL
be	NULL
maintained	NULL
by	NULL
stochastically	NULL
activating	NULL
lineage-determination	NULL
genes	NULL
at	NULL
a	NULL
low	NULL
frequency	NULL
and	NULL
efficiency	NULL
,	NULL
which	NULL
may	NULL
results	NULL
in	NULL
the	NULL
transcription	NULL
of	NULL
only	NULL
one	NULL
of	NULL
the	NULL
two	NULL
alleles	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

The	NULL
monoallel-	NULL
lineage	NULL
commitment	NULL
Aochastic	NULL
firing	NULL
7	NULL
)	NULL
!	NULL

low	NULL
efficiency	NULL
l	NULL
of	NULL
Pax	NULL
transcription	NULL
progenitor	NULL
\	NULL
X	NULL
1	NULL
(	NULL
not	NULL
2	NULL
)	NULL
Pax	NULL
allele	NULL
transcribed	NULL
self	NULL
renewal	NULL
differentiation	NULL
no	NULL
Pax	NULL
allele	NULL
transcribed	NULL
Fig	NULL
.	NULL

7	NULL
-	NULL
Stochastic	NULL
Activation	NULL
of	NULL
a	NULL
Lineage	NULL
Determination	NULL
Gene	NULL
during	NULL
the	NULL
Commitment	NULL
Phase	NULL
of	NULL
Differentiation	NULL
.	NULL

The	NULL
commitment	NULL
of	NULL
progenitor	NULL
cells	NULL
to	NULL
a	NULL
particular	NULL
cell	NULL
lineage	NULL
may	NULL
be	NULL
brought	NULL
about	NULL
by	NULL
the	NULL
stochastic	NULL
activation	NULL
of	NULL
alineage	NULL
determination	NULL
gene	NULL
such	NULL
as	NULL
which	NULL
could	NULL
result	NULL
in	NULL
expression	NULL
of	NULL
only	NULL
one	NULL
of	NULL
the	NULL
two	NULL
alleles	NULL
due	NULL
to	NULL
low	NULL
efficiency	NULL
of	NULL
transcription	NULL
ini-tiation	NULL
.	NULL

ic	NULL
expression	NULL
of	NULL
Pax5	NULL
in	NULL
pro-	NULL
B	NULL
cells	NULL
is	NULL
therefore	NULL
consistent	NULL
with	NULL
a	NULL
stochastic	NULL
model	NULL
of	NULL
B-lineage	NULL
commitment	NULL
.	NULL

In	NULL
this	NULL
context	NULL
it	NULL
may	NULL
be	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
the	NULL
transcription	NULL
of	NULL
several	NULL
other	NULL
lineage-specific	NULL
genes	NULL
is	NULL
also	NULL
initiated	NULL
only	NULL
at	NULL
a	NULL
low	NULL
level	NULL
in	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
(	NULL
Hu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
,	NULL
and	NULL
references	NULL
therein	NULL
}	NULL
.	NULL

Monoallelic	NULL
Expression	NULL
May	NULL
be	NULL
More	NULL
Common	NULL
in	NULL
Mammals	NULL
than	NULL
Previously	NULL
Anticipated	NULL
The	NULL
majority	NULL
of	NULL
mutations	NULL
in	NULL
mouse	NULL
and	NULL
human	NULL
genes	NULL
are	NULL
recessive	NULL
,	NULL
indicating	NULL
that	NULL
expression	NULL
from	NULL
both	NULL
alleles	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
the	NULL
function	NULL
of	NULL
most	NULL
genes	NULL
in	NULL
vivo	NULL
.	NULL

A	NULL
small	NULL
proportion	NULL
of	NULL
mammalian	NULL
genes	NULL
(	NULL
0.1	NULL
%	NULL
-02	NULL
%	NULL
)	NULL
is	NULL
,	NULL
however	NULL
,	NULL
Monoallelic	NULL
Transcription	NULL
of	NULL
Pax	NULL
Genes	NULL
609	NULL
monoallelically	NULL
expressed	NULL
as	NULL
a	NULL
result	NULL
of	NULL
genomic	NULL
imprint-ing	NULL
,	NULL
while	NULL
the	NULL
extent	NULL
of	NULL
non-imprinted	NULL
genes	NULL
displaying	NULL
monoallelic	NULL
expression	NULL
is	NULL
not	NULL
yet	NULL
known	NULL
(	NULL
Watanabe	NULL
and	NULL
Barlow	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

Random	NULL
monoallelic	NULL
expression	NULL
has	NULL
been	NULL
first	NULL
described	NULL
for	NULL
the	NULL
family	NULL
of	NULL
odorant	NULL
receptor	NULL
genes	NULL
(	NULL
Chess	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
monoallelic	NULL
transcription	NULL
is	NULL
a	NULL
mechanism	NULL
to	NULL
ensure	NULL
that	NULL
each	NULL
individual	NULL
sensory	NULL
neuron	NULL
of	NULL
the	NULL
olfactory	NULL
system	NULL
expresses	NULL
only	NULL
a	NULL
single	NULL
receptor	NULL
on	NULL
the	NULL
surface	NULL
.	NULL

The	NULL
lymphoid	NULL
system	NULL
,	NULL
which	NULL
is	NULL
more	NULL
amenable	NULL
to	NULL
analysis	NULL
at	NULL
the	NULL
single	NULL
cell	NULL
level	NULL
,	NULL
has	NULL
provided	NULL
further	NULL
insight	NULL
into	NULL
the	NULL
regulation	NULL
of	NULL
monoallelic	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
Ly49	NULL
gene	NULL
family	NULL
codes	NULL
for	NULL
MHC	NULL
class	NULL
|-specific	NULL
inhibitory	NULL
receptors	NULL
which	NULL
are	NULL
expressed	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cells	NULL
where	NULL
they	NULL
participate	NULL
in	NULL
the	NULL
discrimination	NULL
of	NULL
self	NULL
from	NULL
nonself	NULL
in	NULL
innate	NULL
immunity	NULL
(	NULL
Long	NULL
and	NULL
Wagtmann	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
individual	NULL
alleles	NULL
of	NULL
these	NULL
Ly49	NULL
genes	NULL
are	NULL
stochastically	NULL
chosen	NULL
for	NULL
stable	NULL
expression	NULL
in	NULL
different	NULL
NK	NULL
cells	NULL
.	NULL

Monoallelic	NULL
expression	NULL
of	NULL
the	NULL
Ly49	NULL
genes	NULL
is	NULL
therefore	NULL
thought	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
generating	NULL
a	NULL
diverse	NULL
repertoire	NULL
of	NULL
NK	NULL
cell	NULL
receptors	NULL
(	NULL
Held	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Held	NULL
and	NULL
Raulet	NULL
,	NULL
1997	NULL
;	NULL
Held	NULL
and	NULL
Kunz	NULL
,	NULL
1998	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
the	NULL
analysis	NULL
of	NULL
wild-type	NULL
T	NULL
cells	NULL
and	NULL
heterozygous	NULL
mutant	NULL
mice	NULL
has	NULL
revealed	NULL
that	NULL
individual	NULL
alleles	NULL
of	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
genes	NULL
are	NULL
independently	NULL
regulated	NULL
by	NULL
a	NULL
stochastic	NULL
process	NULL
in	NULL
T	NULL
helper	NULL
cells	NULL
(	NULL
Hollander	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Bix	NULL
and	NULL
Locksley	NULL
,	NULL
1998	NULL
;	NULL
RiviÃ©re	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Allele-specific	NULL
regulation	NULL
may	NULL
therefore	NULL
establish	NULL
a	NULL
diverse	NULL
repertoire	NULL
of	NULL
combinatorially	NULL
assorted	NULL
cytokine	NULL
expression	NULL
patterns	NULL
in	NULL
T	NULL
lymphocytes	NULL
(	NULL
Bix	NULL
and	NULL
Locksley	NULL
,	NULL
1998	NULL
;	NULL
Riviere	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Several	NULL
human	NULL
disease	NULL
syndromes	NULL
are	NULL
caused	NULL
by	NULL
heterozygous	NULL
mutations	NULL
in	NULL
transcription	NULL
factor	NULL
genes	NULL
other	NULL
than	NULL
PAX	NULL
genes	NULL
(	NULL
MITF	NULL
,	NULL
HOXD13	NULL
,	NULL
EMX2	NULL
,	NULL
GLI3	NULL
,	NULL
THRB	NULL
,	NULL
HMGIC	NULL
,	NULL
SOXS	NULL
,	NULL
SOX10	NULL
,	NULL
CBP	NULL
,	NULL
EYA1	NULL
,	NULL
CBFA1	NULL
)	NULL
(	NULL
Engelkamp	NULL
and	NULL
van	NULL
Heyningen	NULL
,	NULL
1996	NULL
,	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
.	NULL

It	NULL
will	NULL
be	NULL
important	NULL
to	NULL
see	NULL
whether	NULL
monoallelic	NULL
expression	NULL
of	NULL
some	NULL
ofthese	NULL
genes	NULL
may	NULL
be	NULL
the	NULL
underlying	NULL
disease-caus-ing	NULL
mechanism	NULL
.	NULL

An	NULL
interesting	NULL
case	NULL
in	NULL
this	NULL
repect	NULL
is	NULL
CBFA1	NULL
,	NULL
which	NULL
upon	NULL
mutation	NULL
causes	NULL
the	NULL
cleidocranial	NULL
dysplasia	NULL
syndrome	NULL
(	NULL
Lee	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Mundlos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Targeted	NULL
gene	NULL
inactivation	NULL
in	NULL
the	NULL
mouse	NULL
identified	NULL
Cbfa1	NULL
as	NULL
a	NULL
key	NULL
regulator	NULL
of	NULL
osteoblast	NULL
differentiation	NULL
(	NULL
Otto	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Komori	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
transcription	NULL
factor	NULL
may	NULL
be	NULL
essential	NULL
for	NULL
commitment	NULL
to	NULL
the	NULL
osteoblast	NULL
lineage	NULL
similar	NULL
to	NULL
the	NULL
role	NULL
of	NULL
Pax5	NULL
in	NULL
B	NULL
cell	NULL
development	NULL
.	NULL

Acknowledgements	NULL
This	NULL
review	NULL
is	NULL
a	NULL
late	NULL
contribution	NULL
to	NULL
the	NULL
highlight	NULL
issue	NULL
of	NULL
March	NULL
'99	NULL
which	NULL
is	NULL
dedicated	NULL
to	NULL
Max	NULL
L.	NULL
Birnstiel	NULL
,	NULL
the	NULL
founding	NULL
director	NULL
of	NULL
the	NULL
Research	NULL
Institute	NULL
of	NULL
Molecular	NULL
Pathology	NULL
in	NULL
Vienna	NULL
.	NULL

Meinrad	NULL
Busslinger	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
Max	NULL
Birnstie	NULL
!	NULL

for	NULL
many	NULL
years	NULL
of	NULL
scientific	NULL
advice	NULL
,	NULL
support	NULL
and	NULL
encouragement	NULL
.	NULL

We	NULL
are	NULL
furthermore	NULL
grateful	NULL
to	NULL
E.	NULL
ten	NULL
Boekel	NULL
for	NULL
advice	NULL
on	NULL
single-cell	NULL
RT-PCR	NULL
,	NULL
to	NULL
A.	NULL
Souabni	NULL
for	NULL
cloning	NULL
polymorphic	NULL
Pax5	NULL
and	NULL
CD19	NULL
cDNA	NULL
,	NULL
to	NULL
P.	NULL
Steinlein	NULL
for	NULL
FACS	NULL
sorting	NULL
and	NULL
to	NULL
L.	NULL
Huber	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Research	NULL
Insti-	NULL
610	NULL
-	NULL
S.L	NULL
.	NULL

Nutt	NULL
etal	NULL
.	NULL

tute	NULL
of	NULL
Molecular	NULL
Pathology	NULL
and	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Austrian	NULL
Industrial	NULL
Research	NULL
Promotion	NULL
fund	NULL
.	NULL

References	NULL
Adams	NULL
,	NULL
B.	NULL
,	NULL
Dorfler	NULL
,	NULL
P.	NULL
,	NULL
Aguzzi	NULL
,	NULL
A.	NULL
,	NULL
Kozmik	NULL
,	NULL
Z.	NULL
,	NULL
Urbanek	NULL
,	NULL
P.	NULL
,	NULL
Maurer	NULL
Fogy	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Busslinger	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Pax-5	NULL
encodes	NULL
the	NULL
transcription	NULL
factor	NULL
BSAP	NULL
and	NULL
is	NULL
expressed	NULL
in	NULL
B	NULL
lymphocytes	NULL
,	NULL
the	NULL
developing	NULL
CNS	NULL
,	NULL
and	NULL
adult	NULL
testis	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
1589-1607	NULL
.	NULL

Bain	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Murre	NULL
,	NULL
C.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
E-proteins	NULL
in	NULL
B-	NULL
and	NULL
T-lymphocyte	NULL
development	NULL
.	NULL

Sem	NULL
.	NULL

Immunol	NULL
.	NULL

10	NULL
,	NULL
143-153	NULL
.	NULL

Bain	NULL
,	NULL
G.	NULL
,	NULL
Maandag	NULL
,	NULL
E.C.R	NULL
.	NULL

,	NULL
Izon	NULL
,	NULL
D.J	NULL
.	NULL

,	NULL
Amsen	NULL
,	NULL
D.	NULL
,	NULL
Kruisbeek	NULL
,	NULL
A.M.	NULL
,	NULL
Weintraub	NULL
,	NULL
B.C	NULL
.	NULL

,	NULL
Krop	NULL
,	NULL
I.	NULL
,	NULL
Schlissel	NULL
,	NULL
M.S	NULL
.	NULL

,	NULL
Feeney	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
van	NULL
Roon	NULL
,	NULL
M.	NULL
,	NULL
van	NULL
der	NULL
Valk	NULL
,	NULL
M.	NULL
,	NULL
te	NULL
Riele	NULL
,	NULL
H.PJ	NULL
.	NULL

,	NULL
Berns	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Murre	NULL
,	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

E2A	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
proper	NULL
B	NULL
cell	NULL
development	NULL
and	NULL
initiation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
rearrange-ments	NULL
.	NULL

Cell	NULL
79	NULL
,	NULL
885-892	NULL
.	NULL

Baldwin	NULL
,	NULL
C.T	NULL
.	NULL

,	NULL
Hoth	NULL
,	NULL
C.F	NULL
.	NULL

,	NULL
Amos	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
da-Silva	NULL
,	NULL
E.O	NULL
.	NULL

,	NULL
and	NULL
Milun-sky	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

An	NULL
exonic	NULL
mutation	NULL
in	NULL
the	NULL
HuP2	NULL
paired	NULL
domain	NULL
gene	NULL
causes	NULL
Waardenburg	NULL
's	NULL
syndrome	NULL
.	NULL

Nature	NULL
355	NULL
,	NULL
637-638	NULL
.	NULL

Barlow	NULL
,	NULL
D.P	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Gametic	NULL
imprinting	NULL
in	NULL
mammals	NULL
.	NULL

Science	NULL
270	NULL
,	NULL
1610-1613	NULL
.	NULL

Bix	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Locksley	NULL
,	NULL
R.M	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Independent	NULL
and	NULL
epigentic	NULL
regulation	NULL
of	NULL
the	NULL
interleukin-4	NULL
alleles	NULL
in	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

Science	NULL
281	NULL
,	NULL
1352-1354	NULL
.	NULL

Bopp	NULL
,	NULL
D.	NULL
,	NULL
Burri	NULL
,	NULL
M.	NULL
,	NULL
Baumgartner	NULL
,	NULL
S.	NULL
,	NULL
Frigerio	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Noll	NULL
,	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
.	NULL

Conservation	NULL
of	NULL
a	NULL
large	NULL
protein	NULL
domain	NULL
in	NULL
the	NULL
segmen-	NULL
tation	NULL
gene	NULL
paired	NULL
and	NULL
in	NULL
functionally	NULL
related	NULL
genes	NULL
of	NULL
Droso-phila	NULL
.	NULL

Cell	NULL
47	NULL
,	NULL
1033-1040	NULL
.	NULL

Busslinger	NULL
,	NULL
M.	NULL
,	NULL
Klix	NULL
,	NULL
N.	NULL
,	NULL
Pfeffer	NULL
,	NULL
P.	NULL
,	NULL
Graninger	NULL
,	NULL
PG	NULL
.	NULL

,	NULL
and	NULL
Kozmik	NULL
,	NULL
Z	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Deregulation	NULL
of	NULL
PAX-5	NULL
by	NULL
translocation	NULL
of	NULL
the	NULL
Ep	NULL
enhancer	NULL
of	NULL
the	NULL
igH	NULL
locus	NULL
adjacent	NULL
to	NULL
two	NULL
alternative	NULL
PAX-5	NULL
promoters	NULL
in	NULL
a	NULL
diffuse	NULL
large-cell	NULL
lymphoma	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
,	NULL
6129-6134	NULL
.	NULL

Callaerts	NULL
,	NULL
P.	NULL
,	NULL
Halder	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Gehring	NULL
,	NULL
W.J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Pax-6	NULL
in	NULL
devel-	NULL
opment	NULL
and	NULL
evolution	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Neurosci	NULL
.	NULL

20	NULL
,	NULL
483-532	NULL
.	NULL

Chess	NULL
,	NULL
A.	NULL
,	NULL
Simon	NULL
,	NULL
I.	NULL
,	NULL
Cedar	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Axel	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Allelic	NULL
inacti-	NULL
vation	NULL
regulates	NULL
olfactory	NULL
receptor	NULL
gene	NULL
expression	NULL
.	NULL

Cell	NULL
78	NULL
,	NULL
823-834	NULL
.	NULL

Cline	NULL
,	NULL
TW	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
Drosophila	NULL
sex	NULL
determination	NULL
signal	NULL
:	NULL
how	NULL
do	NULL
flies	NULL
count	NULL
to	NULL
two	NULL
?	NULL

Tends	NULL
Genet	NULL
.	NULL

9	NULL
,	NULL
385-390	NULL
.	NULL

Czerny	NULL
,	NULL
T.	NULL
,	NULL
Schaffner	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Busslinger	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

DNA	NULL
sequence	NULL
recognition	NULL
by	NULL
Pax	NULL
proteins	NULL
:	NULL
bipartite	NULL
structure	NULL
of	NULL
the	NULL
paired	NULL
domain	NULL
and	NULL
its	NULL
binding	NULL
site	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
2048-2061	NULL
.	NULL

Engelkamp	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
van	NULL
Heyningen	NULL
,	NULL
V.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Transcription	NULL
factors	NULL
in	NULL
disease	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

6	NULL
,	NULL
334-342	NULL
.	NULL

Epstein	NULL
,	NULL
D.J	NULL
.	NULL

,	NULL
Vekemans	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Gros	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Splotch	NULL
(	NULL
SpZH	NULL
)	NULL
,	NULL
a	NULL
mutation	NULL
affecting	NULL
development	NULL
of	NULL
the	NULL
mouse	NULL
neural	NULL
tube	NULL
,	NULL
shows	NULL
a	NULL
deletion	NULL
within	NULL
the	NULL
paired	NULL
homeodomain	NULL
of	NULL
Pax-3	NULL
.	NULL

Cell	NULL
67	NULL
,	NULL
767-774	NULL
.	NULL

Fisher	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Scambler	NULL
,	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Human	NULL
haploinsufficiency	NULL
one	NULL
for	NULL
sorrow	NULL
,	NULL
two	NULL
for	NULL
joy	NULL
.	NULL

Nature	NULL
Genet	NULL
.	NULL

7	NULL
,	NULL
5-7	NULL
.	NULL

Forejt	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Gregorova	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Genetic	NULL
analysis	NULL
of	NULL
genomic	NULL
imprinting	NULL
:	NULL
an	NULL
imprintor-1	NULL
gene	NULL
controls	NULL
inactivation	NULL
of	NULL
the	NULL
paternal	NULL
copy	NULL
of	NULL
the	NULL
mouse	NULL
Tmelocus	NULL
.	NULL

Cell	NULL
70	NULL
,	NULL
443-450	NULL
.	NULL

Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
Moore	NULL
,	NULL
D.D	NULL
.	NULL

,	NULL
and	NULL
Derfler	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Ikaros	NULL
,	NULL
an	NULL
early	NULL
lymphoid-specific	NULL
transcription	NULL
factor	NULL
and	NULL
a	NULL
putative	NULL
mediator	NULL
for	NULL
T	NULL
cell	NULL
commitment	NULL
.	NULL

Science	NULL
258	NULL
,	NULL
808-812	NULL
.	NULL

Gorman	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
van	NULL
der	NULL
Stoep	NULL
,	NULL
N.	NULL
,	NULL
Monroe	NULL
,	NULL
R.	NULL
,	NULL
Cogne	NULL
,	NULL
M.	NULL
,	NULL
David-son	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Alt	NULL
,	NULL
EW	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
Igx	NULL
3	NULL
``	NULL
enhancer	NULL
influences	NULL
the	NULL
ratio	NULL
of	NULL
Ig	NULL
versus	NULL
IgA	NULL
B	NULL
lymphocytes	NULL
.	NULL

Immunity	NULL
5	NULL
,	NULL
241-252	NULL
.	NULL

Hanson	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
van	NULL
Heyningen	NULL
,	NULL
V.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Pax6	NULL
:	NULL
more	NULL
than	NULL
meets	NULL
the	NULL
eye	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

11	NULL
,	NULL
268-272	NULL
.	NULL

Hanson	NULL
,	NULL
|.M	NULL
.	NULL

,	NULL
Fletcher	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Jordan	NULL
,	NULL
T.	NULL
,	NULL
Brown	NULL
,	NULL
A.	NULL
,	NULL
Taylor	NULL
,	NULL
D.	NULL
,	NULL
Adams	NULL
,	NULL
R.J.	NULL
,	NULL
Punnett	NULL
,	NULL
H.H	NULL
.	NULL

,	NULL
and	NULL
van	NULL
Heyningen	NULL
,	NULL
V.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Mutations	NULL
at	NULL
the	NULL
PAX6	NULL
locus	NULL
are	NULL
found	NULL
in	NULL
heterogeneous	NULL
anterior	NULL
segment	NULL
malformations	NULL
including	NULL
Peters	NULL
'	NULL
anomaly	NULL
.	NULL

Nature	NULL
Genet	NULL
.	NULL

6	NULL
,	NULL
168-173	NULL
.	NULL

Held	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Raulet	NULL
,	NULL
D.H.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
Ly49A	NULL
gene	NULL
in	NULL
murine	NULL
natural	NULL
killer	NULL
cell	NULL
clones	NULL
is	NULL
predominantly	NULL
but	NULL
not	NULL
exclusively	NULL
mono-allelic	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

27	NULL
,	NULL
2876-2884	NULL
.	NULL

Held	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Kunz	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

An	NULL
allele-specific	NULL
,	NULL
stochastic	NULL
gene	NULL
expression	NULL
process	NULL
controls	NULL
the	NULL
expression	NULL
of	NULL
multiple	NULL
Ly49	NULL
family	NULL
genes	NULL
and	NULL
generates	NULL
a	NULL
diverse	NULL
,	NULL
MHC-specific	NULL
NK	NULL
cell	NULL
receptor	NULL
repertoire	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28	NULL
,	NULL
2407-2416	NULL
.	NULL

Held	NULL
,	NULL
W.	NULL
,	NULL
Roland	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Raulet	NULL
,	NULL
D.H.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Allelic	NULL
exclusion	NULL
of	NULL
Ly49-family	NULL
genes	NULL
encoding	NULL
class	NULL
|	NULL
MHC-specific	NULL
receptors	NULL
on	NULL
NK	NULL
cells	NULL
.	NULL

Nature	NULL
376	NULL
,	NULL
355-358	NULL
.	NULL

Hill	NULL
,	NULL
R.E	NULL
.	NULL

,	NULL
Favor	NULL
,	NULL
J.	NULL
,	NULL
Hogan	NULL
,	NULL
B.L	NULL
.	NULL

,	NULL
Ton	NULL
,	NULL
C.C	NULL
.	NULL

,	NULL
Saunders	NULL
,	NULL
G.E	NULL
.	NULL

,	NULL
Hanson	NULL
,	NULL
.M	NULL
.	NULL

,	NULL
Prosser	NULL
,	NULL
J.	NULL
,	NULL
Jordan	NULL
,	NULL
T.	NULL
,	NULL
Hastie	NULL
,	NULL
N.D.	NULL
,	NULL
and	NULL
van	NULL
Heyningen	NULL
,	NULL
V.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Mouse	NULL
Smail	NULL
eye	NULL
results	NULL
from	NULL
mutations	NULL
in	NULL
a	NULL
paired	NULL
-like	NULL
homeobox-containing	NULL
gene	NULL
.	NULL

Nature	NULL
354	NULL
,	NULL
522-525	NULL
.	NULL

Hollander	NULL
,	NULL
G.A	NULL
.	NULL

,	NULL
Zuklys	NULL
,	NULL
S.	NULL
,	NULL
Morel	NULL
,	NULL
C.	NULL
,	NULL
Mizoguchi	NULL
,	NULL
E.	NULL
,	NULL
Mobisson	NULL
,	NULL
K.	NULL
,	NULL
Simpson	NULL
,	NULL
S.	NULL
,	NULL
Terhorst	NULL
,	NULL
C.	NULL
,	NULL
Wishart	NULL
,	NULL
W.	NULL
,	NULL
Golan	NULL
,	NULL
D.E	NULL
.	NULL

,	NULL
Bhan	NULL
,	NULL
AK	NULL
.	NULL

,	NULL
and	NULL
Burakoff	NULL
,	NULL
S.J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Monoallelic	NULL
expression	NULL
of	NULL
the	NULL
interleukin-2	NULL
locus	NULL
.	NULL

Science	NULL
279	NULL
,	NULL
2118-2121	NULL
.	NULL

Hu	NULL
,	NULL
M.	NULL
,	NULL
Krause	NULL
,	NULL
D.	NULL
,	NULL
Greaves	NULL
,	NULL
M.	NULL
,	NULL
Sharkis	NULL
,	NULL
S.	NULL
,	NULL
Dexter	NULL
,	NULL
M.	NULL
,	NULL
Hey-worth	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Enver	NULL
,	NULL
T.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Multilineage	NULL
gene	NULL
expression	NULL
precedes	NULL
commitment	NULL
in	NULL
the	NULL
hematopoietic	NULL
system	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

11	NULL
,	NULL
774-785	NULL
.	NULL

Johnson	NULL
,	NULL
C.V.	NULL
,	NULL
Singer	NULL
,	NULL
R.H.	NULL
,	NULL
and	NULL
Lawrence	NULL
,	NULL
J.B.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Fluores-	NULL
cent	NULL
detection	NULL
of	NULL
nuclear	NULL
RNA	NULL
and	NULL
DNA	NULL
:	NULL
Implications	NULL
for	NULL
genome	NULL
organization	NULL
.	NULL

Methods	NULL
Cell	NULL
Biol	NULL
.	NULL

35	NULL
,	NULL
73-99	NULL
.	NULL

Keller	NULL
,	NULL
S.A.	NULL
,	NULL
Jones	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Boyle	NULL
,	NULL
A.	NULL
,	NULL
Barrow	NULL
,	NULL
L.L	NULL
.	NULL

,	NULL
Killen	NULL
,	NULL
PD	NULL
.	NULL

,	NULL
Green	NULL
,	NULL
D.G	NULL
.	NULL

,	NULL
Kapousta	NULL
,	NULL
N.V.	NULL
,	NULL
Hitchcock	NULL
,	NULL
PE	NULL
,	NULL
Swank	NULL
,	NULL
R.T.	NULL
,	NULL
and	NULL
Meisler	NULL
,	NULL
M.H	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Kidney	NULL
and	NULL
retinal	NULL
defects	NULL
(	NULL
Krd	NULL
)	NULL
,	NULL
a	NULL
trans-gene-induced	NULL
mutation	NULL
with	NULL
a	NULL
deletion	NULL
of	NULL
mouse	NULL
chromosome	NULL
19	NULL
that	NULL
includes	NULL
the	NULL
Pax2	NULL
locus	NULL
.	NULL

Genomics	NULL
23	NULL
,	NULL
309-320	NULL
.	NULL

Komori	NULL
,	NULL
T.	NULL
,	NULL
Yagi	NULL
,	NULL
H.	NULL
,	NULL
Nomura	NULL
,	NULL
S.	NULL
,	NULL
Yamaguchi	NULL
,	NULL
A.	NULL
,	NULL
Sasaki	NULL
,	NULL
K.	NULL
,	NULL
Deguchi	NULL
,	NULL
K.	NULL
,	NULL
Shimizu	NULL
,	NULL
Y.	NULL
,	NULL
Bronson	NULL
,	NULL
R.T.	NULL
,	NULL
Gao	NULL
,	NULL
Y.-H.	NULL
,	NULL
Inada	NULL
,	NULL
M.	NULL
,	NULL
Sato	NULL
,	NULL
M.	NULL
,	NULL
Okamoto	NULL
,	NULL
R.	NULL
,	NULL
Kitamura	NULL
,	NULL
Y.	NULL
,	NULL
Yoshiki	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Kishimo-to	NULL
,	NULL
T.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
Cbfa	NULL
?	NULL

results	NULL
in	NULL
a	NULL
complete	NULL
lack	NULL
of	NULL
bone	NULL
formation	NULL
owing	NULL
to	NULL
maturational	NULL
arrest	NULL
of	NULL
os-teoblasts	NULL
.	NULL

Cell	NULL
89	NULL
,	NULL
755-764	NULL
.	NULL

Kozmik	NULL
,	NULL
Z.	NULL
,	NULL
Wang	NULL
,	NULL
S.	NULL
,	NULL
Dorfler	NULL
,	NULL
P.	NULL
,	NULL
Adams	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Busslinger	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
is	NULL
a	NULL
target	NULL
for	NULL
the	NULL
B-	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
BSAP	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
2662-2672	NULL
.	NULL

Lee	NULL
,	NULL
B.	NULL
,	NULL
Thirunavukkarasu	NULL
,	NULL
K.	NULL
,	NULL
Zhou	NULL
,	NULL
L.	NULL
,	NULL
Pastore	NULL
,	NULL
L.	NULL
,	NULL
Baldini	NULL
,	NULL
A.	NULL
,	NULL
Hecht	NULL
,	NULL
J.	NULL
,	NULL
Geoffroy	NULL
,	NULL
V.	NULL
,	NULL
Ducy	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Karsenty	NULL
,	NULL
G.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Mis-sense	NULL
mutations	NULL
abolishing	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
osteoblast-specific	NULL
transcription	NULL
factor	NULL
OSFZ/CBFA	NULL
1	NULL
in	NULL
cleidocranial	NULL
dysplasia	NULL
.	NULL

Nature	NULL
Genet	NULL
.	NULL

16	NULL
,	NULL
307-310	NULL
.	NULL

Long	NULL
,	NULL
E.0	NULL
.	NULL

,	NULL
and	NULL
Wagtmann	NULL
,	NULL
N.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Natural	NULL
killer	NULL
cell	NULL
receptors	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

9	NULL
,	NULL
344-350	NULL
.	NULL

Macchia	NULL
,	NULL
PE	NULL
.	NULL

,	NULL
Lapi	NULL
,	NULL
P.	NULL
,	NULL
Krude	NULL
,	NULL
H.	NULL
,	NULL
Pirro	NULL
,	NULL
M.T	NULL
.	NULL

,	NULL
Missero	NULL
,	NULL
C.	NULL
,	NULL
Chiova-to	NULL
,	NULL
L.	NULL
,	NULL
Souabni	NULL
,	NULL
A.	NULL
,	NULL
Baserga	NULL
,	NULL
M.	NULL
,	NULL
Tassi	NULL
,	NULL
V.	NULL
,	NULL
Pinchera	NULL
,	NULL
A.	NULL
,	NULL
Fenzi	NULL
,	NULL
G.	NULL
,	NULL
Gruters	NULL
,	NULL
A.	NULL
,	NULL
Busslinger	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Di	NULL
Lauro	NULL
,	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

PAX8	NULL
mutations	NULL
associated	NULL
with	NULL
congenital	NULL
hypothyroidism	NULL
caused	NULL
by	NULL
thyroid	NULL
dysgenesis	NULL
.	NULL

Nature	NULL
Genet	NULL
.	NULL

19	NULL
,	NULL
83-86	NULL
.	NULL

Mansouri	NULL
,	NULL
A.	NULL
,	NULL
Hallonet	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Gruss	NULL
,	NULL
P.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Pax	NULL
genes	NULL
and	NULL
their	NULL
roles	NULL
in	NULL
cell	NULL
differentiation	NULL
and	NULL
development	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

8	NULL
,	NULL
851-857	NULL
.	NULL

Mundlos	NULL
,	NULL
S.	NULL
,	NULL
Otto	NULL
,	NULL
E	NULL
,	NULL
Mundlos	NULL
,	NULL
C.	NULL
,	NULL
Mulliken	NULL
,	NULL
J.B.	NULL
,	NULL
Ayisworth	NULL
,	NULL
A.S.	NULL
,	NULL
Albright	NULL
,	NULL
S.	NULL
,	NULL
Lindhout	NULL
,	NULL
D.	NULL
,	NULL
Cole	NULL
,	NULL
W.G	NULL
.	NULL

,	NULL
Henn	NULL
,	NULL
W.	NULL
,	NULL
Knoll	NULL
,	NULL
J.H.M	NULL
.	NULL

,	NULL
Owen	NULL
,	NULL
M.J.	NULL
,	NULL
Mertelsmann	NULL
,	NULL
R.	NULL
,	NULL
Zabel	NULL
,	NULL
B.U	NULL
.	NULL

,	NULL
and	NULL
Olsen	NULL
,	NULL
B.R	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Mutations	NULL
involving	NULL
the	NULL
transcription	NULL
factor	NULL
CBFA1	NULL
cause	NULL
cleidocranial	NULL
dysplasia	NULL
.	NULL

Cell	NULL
89	NULL
,	NULL
773-779	NULL
.	NULL

Noll	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Evolution	NULL
and	NULL
role	NULL
of	NULL
Pax	NULL
genes	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

3	NULL
,	NULL
595-605	NULL
.	NULL

Nutt	NULL
,	NULL
S.L	NULL
.	NULL

,	NULL
Urbanek	NULL
,	NULL
P.	NULL
,	NULL
Rolink	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Busslinger	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Essential	NULL
functions	NULL
of	NULL
Pax5	NULL
(	NULL
BSAP	NULL
)	NULL
in	NULL
pro-	NULL
B	NULL
cell	NULL
development	NULL
:	NULL
difference	NULL
between	NULL
fetal	NULL
and	NULL
adult	NULL
B	NULL
lymphopoiesis	NULL
and	NULL
reduced	NULL
Vto-	NULL
DJ	NULL
recombination	NULL
at	NULL
the	NULL
igHlocus	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

11	NULL
,	NULL
476-491	NULL
.	NULL

Nutt	NULL
,	NULL
S.L	NULL
.	NULL

,	NULL
Morrison	NULL
,	NULL
A.M.	NULL
,	NULL
Dorfler	NULL
,	NULL
P.	NULL
,	NULL
Rolink	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Busslinger	NULL
,	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

Identification	NULL
of	NULL
BSAP	NULL
(	NULL
Pax-5	NULL
)	NULL
target	NULL
genes	NULL
in	NULL
early	NULL
B-cell	NULL
development	NULL
by	NULL
loss-	NULL
and	NULL
gain-of-function	NULL
experiments	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

17	NULL
,	NULL
2319-2333	NULL
.	NULL

Nutt	NULL
,	NULL
S.L	NULL
.	NULL

,	NULL
Vambrie	NULL
,	NULL
S.	NULL
,	NULL
Steinlein	NULL
,	NULL
P.	NULL
,	NULL
Kozmik	NULL
,	NULL
Z.	NULL
,	NULL
Rolink	NULL
,	NULL
A.	NULL
,	NULL
Weith	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Busslinger	NULL
,	NULL
M.	NULL
(	NULL
1999	NULL
)	NULL
.	NULL

Independent	NULL
regulation	NULL
of	NULL
the	NULL
two	NULL
Pax5	NULL
alleles	NULL
during	NULL
B-cell	NULL
development	NULL
.	NULL

Nature	NULL
Genet	NULL
.	NULL

21	NULL
,	NULL
390-395	NULL
.	NULL

Olson	NULL
,	NULL
EN	NULL
.	NULL

,	NULL
Arnold	NULL
,	NULL
H.-H.	NULL
,	NULL
Rigby	NULL
,	NULL
PW.J	NULL
.	NULL

,	NULL
and	NULL
Wold	NULL
,	NULL
B.J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Know	NULL
your	NULL
neigbors	NULL
:	NULL
three	NULL
phenotypes	NULL
in	NULL
null	NULL
mutants	NULL
of	NULL
the	NULL
myogenic	NULL
bHLH	NULL
gene	NULL
MRF4	NULL
.	NULL

Cell	NULL
85	NULL
,	NULL
1-4	NULL
.	NULL

Otto	NULL
,	NULL
E.	NULL
,	NULL
Thornell	NULL
,	NULL
A.B	NULL
.	NULL

,	NULL
Crompton	NULL
,	NULL
T.	NULL
,	NULL
Denzel	NULL
,	NULL
A.	NULL
,	NULL
Gilmour	NULL
,	NULL
K.C	NULL
.	NULL

,	NULL
Rosewell	NULL
,	NULL
1.R	NULL
.	NULL

,	NULL
Stamp	NULL
,	NULL
G.W.H	NULL
.	NULL

,	NULL
Beddington	NULL
,	NULL
R.S.P	NULL
.	NULL

,	NULL
Mundlos	NULL
,	NULL
S.	NULL
,	NULL
Olsen	NULL
,	NULL
B.R	NULL
.	NULL

,	NULL
Selby	NULL
,	NULL
PB	NULL
.	NULL

,	NULL
and	NULL
Owen	NULL
,	NULL
M.J.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Cbfa1	NULL
,	NULL
a	NULL
candidate	NULL
gene	NULL
for	NULL
cleidocranial	NULL
dysplasia	NULL
syndrome	NULL
,	NULL
is	NULL
essential	NULL
for	NULL
osteoblast	NULL
differentiation	NULL
and	NULL
bone	NULL
development	NULL
.	NULL

Cell	NULL
89	NULL
,	NULL
765-771	NULL
.	NULL

Panning	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Jaenisch	NULL
,	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

DNA	NULL
hypomethylation	NULL
can	NULL
activate	NULL
Xisf	NULL
expression	NULL
and	NULL
silence	NULL
X-linked	NULL
genes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

10	NULL
,	NULL
1991-2002	NULL
.	NULL

Parkhurst	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
and	NULL
Meneely	NULL
,	NULL
P.M.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Sex	NULL
determination	NULL
and	NULL
dosage	NULL
compensation	NULL
:	NULL
lessons	NULL
from	NULL
flies	NULL
and	NULL
worms	NULL
.	NULL

Science	NULL
264	NULL
,	NULL
924-932	NULL
.	NULL

Read	NULL
,	NULL
A.P	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Pax	NULL
genes	NULL
-	NULL
Paired	NULL
feet	NULL
in	NULL
three	NULL
camps	NULL
.	NULL

Nature	NULL
Genet	NULL
.	NULL

9	NULL
,	NULL
333-334	NULL
.	NULL

Riviere	NULL
,	NULL
I.	NULL
,	NULL
Sunshine	NULL
,	NULL
M.J.	NULL
,	NULL
and	NULL
Littman	NULL
,	NULL
D.R	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
IL-4	NULL
expression	NULL
by	NULL
activation	NULL
of	NULL
individual	NULL
alleles	NULL
.	NULL

Immunity	NULL
9	NULL
,	NULL
217-228	NULL
.	NULL

Sanyanusin	NULL
,	NULL
P.	NULL
,	NULL
Schimmenti	NULL
,	NULL
L.A.	NULL
,	NULL
McNoe	NULL
,	NULL
L.A.	NULL
,	NULL
Ward	NULL
,	NULL
TA	NULL
.	NULL

,	NULL
Pier-pont	NULL
,	NULL
M.E.M	NULL
.	NULL

,	NULL
Sullivan	NULL
,	NULL
M.J.	NULL
,	NULL
Dobyns	NULL
,	NULL
W.B	NULL
.	NULL

,	NULL
and	NULL
Eccles	NULL
,	NULL
M.R	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
PAXZ	NULL
gene	NULL
in	NULL
a	NULL
family	NULL
with	NULL
optic	NULL
nerve	NULL
colombomas	NULL
,	NULL
renal	NULL
anomalies	NULL
and	NULL
vesicoureteral	NULL
reflux	NULL
.	NULL

Nature	NULL
Genet	NULL
.	NULL

9	NULL
,	NULL
358-364	NULL
.	NULL

Sched	NULL
,	NULL
A.	NULL
,	NULL
Ross	NULL
,	NULL
A.	NULL
,	NULL
Lee	NULL
,	NULL
M.	NULL
,	NULL
Engelkamp	NULL
,	NULL
D.	NULL
,	NULL
Rashbass	NULL
,	NULL
P.	NULL
,	NULL
van	NULL
Heyningen	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Hastie	NULL
,	NULL
N.D.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Influence	NULL
of	NULL
PAX6	NULL
gene	NULL
dosage	NULL
on	NULL
development	NULL
:	NULL
overexpression	NULL
causes	NULL
severe	NULL
eye	NULL
abnormalities	NULL
.	NULL

Cell	NULL
86	NULL
,	NULL
71-82	NULL
.	NULL

Schwarz	NULL
,	NULL
M.	NULL
,	NULL
Alvarez-Bolado	NULL
,	NULL
G.	NULL
,	NULL
Urbanek	NULL
,	NULL
P.	NULL
,	NULL
Busslinger	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Gruss	NULL
,	NULL
P.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Conserved	NULL
biological	NULL
function	NULL
between	NULL
Pax-2	NULL
and	NULL
Pax-5	NULL
in	NULL
midbrain	NULL
and	NULL
cerebellum	NULL
development	NULL
:	NULL
Evidence	NULL
from	NULL
targeted	NULL
mutation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
,	NULL
14518-14523	NULL
.	NULL

Monoallelic	NULL
Transcription	NULL
of	NULL
PaxGenes	NULL
611	NULL
Strachan	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Read	NULL
,	NULL
A.P	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

PAXgenes	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

4	NULL
,	NULL
427-438	NULL
.	NULL

Sun	NULL
,	NULL
X.-	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
the	NULL
/d	NULL
?	NULL

gene	NULL
impairs	NULL
mouse	NULL
B	NULL
cell	NULL
development	NULL
.	NULL

Cell	NULL
79	NULL
,	NULL
893-900	NULL
.	NULL

Tassabehji	NULL
,	NULL
M.	NULL
,	NULL
Read	NULL
,	NULL
A.P	NULL
,	NULL
Newton	NULL
,	NULL
VE	NULL
.	NULL

,	NULL
Harris	NULL
,	NULL
R.	NULL
,	NULL
Balling	NULL
,	NULL
R.	NULL
,	NULL
Gruss	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Strachan	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Waardenburg	NULL
's	NULL
syndrome	NULL
patients	NULL
have	NULL
mutations	NULL
in	NULL
the	NULL
human	NULL
homologue	NULL
of	NULL
the	NULL
Pax-3	NULL
paired	NULL
box	NULL
gene	NULL
.	NULL

Nature	NULL
355	NULL
,	NULL
635-636	NULL
.	NULL

Ton	NULL
,	NULL
C.C.T	NULL
.	NULL

,	NULL
Hirvonen	NULL
,	NULL
H.	NULL
,	NULL
Miwa	NULL
,	NULL
H.	NULL
,	NULL
Weil	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
Monaghan	NULL
,	NULL
P.	NULL
,	NULL
Jordan	NULL
,	NULL
T.	NULL
,	NULL
van	NULL
Heyningen	NULL
,	NULL
V.	NULL
,	NULL
Hastie	NULL
,	NULL
N.D.	NULL
,	NULL
Meijers-Heijboer	NULL
,	NULL
H.	NULL
,	NULL
Drechsler	NULL
,	NULL
M.	NULL
,	NULL
Royer-	NULL
Pokora	NULL
,	NULL
B.	NULL
,	NULL
Collins	NULL
,	NULL
F	NULL
,	NULL
Swarcop	NULL
,	NULL
A.	NULL
,	NULL
Strong	NULL
,	NULL
L.C	NULL
.	NULL

,	NULL
and	NULL
Saunders	NULL
,	NULL
G.F.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Positional	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
paired	NULL
box-	NULL
and	NULL
homeobox-containing	NULL
gene	NULL
from	NULL
the	NULL
aniridia	NULL
region	NULL
.	NULL

Cell	NULL
67	NULL
,	NULL
1059-1074	NULL
.	NULL

Urbanek	NULL
,	NULL
P.	NULL
,	NULL
Wang	NULL
,	NULL
Z.-Q	NULL
.	NULL

,	NULL
Fetka	NULL
,	NULL
|	NULL
.	NULL

,	NULL
Wagner	NULL
,	NULL
E.F.	NULL
,	NULL
and	NULL
Busslinger	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Complete	NULL
block	NULL
of	NULL
early	NULL
B	NULL
cell	NULL
differentiation	NULL
and	NULL
altered	NULL
patterning	NULL
of	NULL
the	NULL
posterior	NULL
midbrain	NULL
in	NULL
mice	NULL
lacking	NULL
Pax5/BSAP	NULL
.	NULL

Cell	NULL
79	NULL
,	NULL
901-912	NULL
.	NULL

Urbanek	NULL
,	NULL
P.	NULL
,	NULL
Fetka	NULL
,	NULL
|	NULL
.	NULL

,	NULL
Meisler	NULL
,	NULL
M.H	NULL
.	NULL

,	NULL
and	NULL
Busslinger	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Cooperation	NULL
of	NULL
Pax2	NULL
and	NULL
Pax5	NULL
in	NULL
midbrain	NULL
and	NULL
cerebellum	NULL
development	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
,	NULL
5703-5708	NULL
.	NULL

Vorechovsky	NULL
,	NULL
1.	NULL
,	NULL
Koskinen	NULL
,	NULL
S.	NULL
,	NULL
Paganelli	NULL
,	NULL
R.	NULL
,	NULL
Smith	NULL
,	NULL
E.C.1	NULL
.	NULL

,	NULL
Busslinger	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Hammarstrom	NULL
,	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
PAXS	NULL
gene	NULL
:	NULL
a	NULL
linkage	NULL
and	NULL
mutation	NULL
analysis	NULL
in	NULL
candidate	NULL
human	NULL
primary	NULL
im-munodeficiencies	NULL
.	NULL

Immunogenet	NULL
.	NULL

42	NULL
,	NULL
149-152	NULL
.	NULL

Walther	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Gruss	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Pax-6	NULL
,	NULL
a	NULL
murine	NULL
paired	NULL
box	NULL
gene	NULL
,	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
developing	NULL
CNS	NULL
.	NULL

Development	NULL
113	NULL
,	NULL
1435-1449	NULL
.	NULL

Watanabe	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Barlow	NULL
,	NULL
D.P	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Random	NULL
and	NULL
imprinted	NULL
monoallelic	NULL
expression	NULL
.	NULL

Genes	NULL
Cells	NULL
1	NULL
,	NULL
795-802	NULL
.	NULL

Wijgerde	NULL
,	NULL
M.	NULL
,	NULL
Grosveld	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Fraser	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Transcription	NULL
complex	NULL
stability	NULL
and	NULL
chromatin	NULL
dynamics	NULL
in	NULL
vivo	NULL
.	NULL

Nature	NULL
377	NULL
,	NULL
209-213	NULL
.	NULL

Wilkie	NULL
,	NULL
A.O.M	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
of	NULL
genetic	NULL
dominance	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

Genet	NULL
.	NULL

31	NULL
,	NULL
89-98	NULL
.	NULL

Wilm	NULL
,	NULL
B.E.D	NULL
.	NULL

,	NULL
Peters	NULL
,	NULL
H.	NULL
,	NULL
Balling	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Imai	NULL
,	NULL
K.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
Pax	NULL
?	NULL

defines	NULL
its	NULL
null	NULL
phenotype	NULL
and	NULL
proves	NULL
hap-loinsufficiency	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
,	NULL
8692-8697	NULL
.	NULL

Xu	NULL
,	NULL
W.	NULL
,	NULL
Rould	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
Jun	NULL
,	NULL
S.	NULL
,	NULL
Desplan	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Pabo	NULL
,	NULL
C.O	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Crystal	NULL
structure	NULL
of	NULL
the	NULL
paired	NULL
domain-	NULL
DNA	NULL
complex	NULL
at	NULL
2.5	NULL
A	NULL
resolution	NULL
reveals	NULL
structural	NULL
basis	NULL
for	NULL
Pax	NULL
developmental	NULL
mutations	NULL
.	NULL

Cell	NULL
80	NULL
,	NULL
639-650	NULL
.	NULL

Zhou	NULL
,	NULL
L.-J	NULL
.	NULL

,	NULL
Ord	NULL
,	NULL
D.C.	NULL
,	NULL
Hughes	NULL
,	NULL
A.L	NULL
.	NULL

,	NULL
and	NULL
Tedder	NULL
,	NULL
TF	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Structure	NULL
and	NULL
domain	NULL
organization	NULL
of	NULL
the	NULL
CD19	NULL
antigen	NULL
of	NULL
hu-man	NULL
,	NULL
mouse	NULL
,	NULL
and	NULL
guinea	NULL
pig	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147	NULL
,	NULL
1424-1432	NULL
.	NULL

Zhuang	NULL
,	NULL
Y.	NULL
,	NULL
Soriano	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Weintraub	NULL
,	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
helix-loop-helix	NULL
gene	NULL
E2A	NULL
is	NULL
required	NULL
for	NULL
B	NULL
cell	NULL
formation	NULL
.	NULL

Cell	NULL
79	NULL
,	NULL
875-884	NULL
.	NULL

